Regulatory	O
effects	O
of	O
interleukin-11	B-protein
during	O
acute	O
lung	O
inflammatory	O
injury	O
.	O

The	O
role	O
of	O
interleukin-11	B-protein
(	O
IL-11	B-protein
)	O
was	O
evaluated	O
in	O
the	O
IgG	B-protein
immune	I-protein
complex	I-protein
model	O
of	O
acute	O
lung	O
injury	O
in	O
rats	O
.	O

IL-11	B-RNA
mRNA	I-RNA
and	O
protein	O
were	O
both	O
up-regulated	O
during	O
the	O
course	O
of	O
this	O
inflammatory	O
response	O
.	O

Exogenously	O
administered	O
IL-11	B-protein
substantially	O
reduced	O
,	O
in	O
a	O
dose-dependent	O
manner	O
,	O
the	O
intrapulmonary	O
accumulation	O
of	O
neutrophils	B-cell_type
and	O
the	O
lung	O
vascular	O
leak	O
of	O
albumin	B-protein
.	O

These	O
in	O
vivo	O
anti-inflammatory	O
effects	O
of	O
IL-11	B-protein
were	O
associated	O
with	O
reduced	O
NF-kappaB	B-protein
activation	O
in	O
lung	O
,	O
reduced	O
levels	O
of	O
tumor	B-protein
necrosis	I-protein
factor	I-protein
alpha	I-protein
(	O
TNF-alpha	B-protein
)	O
in	O
bronchoalveolar	O
lavage	O
(	O
BAL	O
)	O
fluids	O
,	O
and	O
diminished	O
up-regulation	O
of	O
lung	B-protein
vascular	I-protein
ICAM-1	I-protein
.	O

It	O
is	O
interesting	O
that	O
IL-11	B-protein
did	O
not	O
affect	O
BAL	O
fluid	O
content	O
of	O
the	O
CXC	B-protein
chemokines	I-protein
,	O
macrophage	B-protein
inflammatory	I-protein
protein-2	I-protein
(	O
MIP-2	B-protein
)	O
and	O
cytokine-inducible	B-protein
neutrophil	I-protein
chemoattractant	I-protein
(	O
CINC	B-protein
)	O
;	O
the	O
presence	O
of	O
IL-11	B-protein
did	O
not	O
affect	O
these	O
chemokines	B-protein
.	O

However	O
,	O
BAL	O
content	O
of	O
C5a	O
was	O
reduced	O
by	O
IL-11	B-protein
.	O

These	O
data	O
indicate	O
that	O
IL-11	B-protein
is	O
a	O
regulatory	B-protein
cytokine	I-protein
in	O
the	O
lung	O
and	O
that	O
,	O
like	O
other	O
members	O
of	O
this	O
family	O
,	O
its	O
anti-inflammatory	O
properties	O
appear	O
to	O
be	O
linked	O
to	O
its	O
suppression	O
of	O
NF-kappaB	B-protein
activation	O
,	O
diminished	O
production	O
of	O
TNF-alpha	B-protein
,	O
and	O
reduced	O
up-regulation	O
of	O
lung	B-protein
vascular	I-protein
ICAM-1	I-protein
.	O

Regulatory	NULL
effects	NULL
of	NULL
interleukin-11	NULL
during	NULL
acute	NULL
lung	NULL
inflammatory	NULL
injury	NULL
Alex	NULL
B.	NULL
Lentsch	NULL
,	NULL
*	NULL
Larry	NULL
D.	NULL
Crouch	NULL
,	NULL
§	NULL
Jacqueline	NULL
A.	NULL
Jordan	NULL
,	NULL
t	NULL
Boris	NULL
J.	NULL
Czermak	NULL
,	NULL
!	NULL

Edward	NULL
C.	NULL
Yun	NULL
,	NULL
t	NULL
Renfeng	NULL
Guo	NULL
,	NULL
t	NULL
Vidya	NULL
Sarma	NULL
,	NULL
!	NULL

Kathleen	NULL
M.	NULL
Dieh	NULL
!	NULL

1	NULL
,	NULL
*	NULL
and	NULL
Peter	NULL
A.	NULL
Wardt	NULL
*Department	NULL
of	NULL
Surgery	NULL
,	NULL
University	NULL
of	NULL
Louisville	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
Kentucky	NULL
;	NULL
Departments	NULL
of	NULL
'Pathology	NULL
&	NULL
*Surgery	NULL
,	NULL
University	NULL
of	NULL
Michigan	NULL
Medical	NULL
School	NULL
,	NULL
Ann	NULL
Arbor	NULL
;	NULL
Department	NULL
of	NULL
Oral	NULL
Biology	NULL
,	NULL
University	NULL
of	NULL
Nebraska	NULL
Medical	NULL
Center	NULL
,	NULL
Lincoln	NULL
;	NULL
and	NULL
Department	NULL
of	NULL
Trauma	NULL
Surgery	NULL
,	NULL
University	NULL
of	NULL
Freiburg	NULL
,	NULL
Germany	NULL
Abstract	NULL
:	NULL
-	NULL
The	NULL
role	NULL
of	NULL
interleukin-11	NULL
(	NULL
IL-11	NULL
)	NULL
was	NULL
evaluated	NULL
in	NULL
the	NULL
IgG	NULL
immune	NULL
complex	NULL
model	NULL
of	NULL
acute	NULL
lung	NULL
injury	NULL
in	NULL
rats	NULL
.	NULL

IL-1	NULL
1	NULL
mRNA	NULL
and	NULL
protein	NULL
were	NULL
both	NULL
up-regulated	NULL
during	NULL
the	NULL
course	NULL
of	NULL
this	NULL
inflammatory	NULL
response	NULL
.	NULL

Exogenously	NULL
administered	NULL
IL-11	NULL
substantially	NULL
reduced	NULL
,	NULL
in	NULL
a	NULL
dose-dependent	NULL
manner	NULL
,	NULL
the	NULL
intrapulmonary	NULL
accumulation	NULL
of	NULL
neutrophils	NULL
and	NULL
the	NULL
lung	NULL
vascular	NULL
leak	NULL
of	NULL
albumin	NULL
.	NULL

These	NULL
in	NULL
vivo	NULL
anti-inflammatory	NULL
effects	NULL
of	NULL
IL-1	NULL
1	NULL
were	NULL
associated	NULL
with	NULL
reduced	NULL
NF-KB	NULL
activation	NULL
in	NULL
lung	NULL
,	NULL
reduced	NULL
levels	NULL
of	NULL
tumor	NULL
necrosis	NULL
factor	NULL
«	NULL
(	NULL
TNF-a	NULL
@	NULL
)	NULL
in	NULL
bronchoalveolar	NULL
lavage	NULL
(	NULL
BAL	NULL
)	NULL
fluids	NULL
,	NULL
and	NULL
diminished	NULL
up-regulation	NULL
of	NULL
lung	NULL
vascular	NULL
ICAM-1	NULL
.	NULL

It	NULL
is	NULL
interesting	NULL
that	NULL
IL-11	NULL
did	NULL
not	NULL
affect	NULL
BAL	NULL
fluid	NULL
content	NULL
of	NULL
the	NULL
CXC	NULL
chemokines	NULL
,	NULL
macrophage	NULL
inflammatory	NULL
protein-2	NULL
(	NULL
MIP-2	NULL
)	NULL
and	NULL
cytokine-inducible	NULL
neutrophil	NULL
chemoattractant	NULL
(	NULL
CINC	NULL
)	NULL
;	NULL
the	NULL
presence	NULL
of	NULL
IL-11	NULL
did	NULL
not	NULL
affect	NULL
these	NULL
chemo-kines	NULL
.	NULL

However	NULL
,	NULL
BAL	NULL
content	NULL
of	NULL
C5	NULL
a	NULL
was	NULL
reduced	NULL
by	NULL
IL-11	NULL
.	NULL

These	NULL
data	NULL
indicate	NULL
that	NULL
IL-11	NULL
is	NULL
a	NULL
regulatory	NULL
cytokine	NULL
in	NULL
the	NULL
lung	NULL
and	NULL
that	NULL
,	NULL
like	NULL
other	NULL
members	NULL
of	NULL
this	NULL
family	NULL
,	NULL
its	NULL
anti-inflammatory	NULL
properties	NULL
appear	NULL
to	NULL
be	NULL
linked	NULL
to	NULL
its	NULL
suppression	NULL
of	NULL
NF-KB	NULL
activation	NULL
,	NULL
diminished	NULL
production	NULL
of	NULL
TNF-	NULL
«	NULL
,	NULL
and	NULL
reduced	NULL
up-regulation	NULL
of	NULL
lung	NULL
vascular	NULL
ICAM-1	NULL
.	NULL

J	NULL
Leukoc	NULL
.	NULL

Biol	NULL
.	NULL

66	NULL
:	NULL
151-157	NULL
;	NULL
1999	NULL
.	NULL

Key	NULL
Words	NULL
:	NULL
neutrophils	NULL
NF-KB	NULL
-	NULL
chemokines	NULL
-	NULL
C5ba	NULL
tumor	NULL
necrosis	NULL
factor	NULL
o	NULL
-	NULL
ICAM-1	NULL
INTRODUCTION	NULL
Interleukin-11	NULL
(	NULL
IL-11	NULL
)	NULL
was	NULL
originally	NULL
identified	NULL
as	NULL
a	NULL
stromal	NULL
cell	NULL
product	NULL
that	NULL
stimulated	NULL
proliferation	NULL
of	NULL
IL-6-dependent	NULL
plasmacytoma	NULL
cells	NULL
[	NULL
1	NULL
]	NULL
.	NULL

Subsequent	NULL
studies	NULL
have	NULL
demonstrated	NULL
that	NULL
IL-11	NULL
has	NULL
effects	NULL
similar	NULL
to	NULL
IL-6	NULL
,	NULL
including	NULL
megakaryocyte	NULL
proliferation	NULL
[	NULL
2	NULL
]	NULL
and	NULL
induction	NULL
of	NULL
acute	NULL
phase	NULL
response	NULL
proteins	NULL
[	NULL
3	NULL
]	NULL
.	NULL

Functional	NULL
similarities	NULL
between	NULL
IL-6	NULL
and	NULL
IL-11	NULL
can	NULL
be	NULL
explained	NULL
by	NULL
the	NULL
fact	NULL
that	NULL
signal	NULL
transduction	NULL
for	NULL
both	NULL
of	NULL
these	NULL
cytokines	NULL
is	NULL
mediated	NULL
through	NULL
the	NULL
transmembrane	NULL
glycoprotein	NULL
130	NULL
(	NULL
gp130	NULL
)	NULL
receptor	NULL
component	NULL
,	NULL
which	NULL
is	NULL
common	NULL
to	NULL
both	NULL
IL-6	NULL
and	NULL
IL-11	NULL
receptor	NULL
complexes	NULL
[	NULL
4	NULL
,	NULL
5	NULL
]	NULL
.	NULL

We	NULL
have	NULL
previously	NULL
shown	NULL
that	NULL
IL-6	NULL
functions	NULL
as	NULL
an	NULL
intrinsic	NULL
regulator	NULL
of	NULL
lung	NULL
inflammation	NULL
induced	NULL
by	NULL
intrapulmonary	NULL
deposition	NULL
of	NULL
IgG	NULL
immune	NULL
complexes	NULL
in	NULL
rats	NULL
[	NULL
6	NULL
]	NULL
.	NULL

The	NULL
development	NULL
of	NULL
lung	NULL
injury	NULL
in	NULL
this	NULL
model	NULL
is	NULL
characterized	NULL
by	NULL
neutrophil	NULL
recruitment	NULL
and	NULL
increased	NULL
vascular	NULL
permeability	NULL
in	NULL
the	NULL
lung	NULL
,	NULL
these	NULL
events	NULL
being	NULL
linked	NULL
to	NULL
production	NULL
of	NULL
TNF-a	NULL
and	NULL
IL-1	NULL
by	NULL
activated	NULL
lung	NULL
macrophages	NULL
[	NULL
7	NULL
,	NULL
8	NULL
]	NULL
.	NULL

Furthermore	NULL
,	NULL
activation	NULL
of	NULL
the	NULL
transcription	NULL
factor	NULL
,	NULL
NF-KB	NULL
,	NULL
occurs	NULL
in	NULL
a	NULL
time	NULL
course	NULL
similar	NULL
to	NULL
that	NULL
for	NULL
the	NULL
appearance	NULL
of	NULL
TNF-a	NULL
and	NULL
IL-1	NULL
[	NULL
9	NULL
]	NULL
.	NULL

In	NULL
this	NULL
model	NULL
of	NULL
lung	NULL
injury	NULL
,	NULL
exogenous	NULL
administration	NULL
of	NULL
IL-6	NULL
caused	NULL
substantial	NULL
reductions	NULL
in	NULL
bronchoalveolar	NULL
lavage	NULL
(	NULL
BAL	NULL
)	NULL
levels	NULL
of	NULL
tumor	NULL
necrosis	NULL
factor	NULL
¢	NULL
(	NULL
TNF-a	NULL
)	NULL
,	NULL
neutrophil	NULL
accumulation	NULL
,	NULL
and	NULL
lung	NULL
vascular	NULL
permeability	NULL
[	NULL
6	NULL
]	NULL
.	NULL

Conversely	NULL
,	NULL
blockade	NULL
of	NULL
endogenous	NULL
IL-6	NULL
augments	NULL
these	NULL
parameters	NULL
of	NULL
lung	NULL
injury	NULL
.	NULL

Recent	NULL
studies	NULL
in	NULL
vitro	NULL
have	NULL
suggested	NULL
that	NULL
IL-11	NULL
suppresses	NULL
proinflammatory	NULL
cytokine	NULL
production	NULL
in	NULL
activated	NULL
macrophages	NULL
by	NULL
attenuating	NULL
NF-KB	NULL
activation	NULL
[	NULL
10	NULL
]	NULL
.	NULL

Other	NULL
studies	NULL
have	NULL
demonstrated	NULL
anti-inflammatory	NULL
effects	NULL
of	NULL
IL-11	NULL
in	NULL
models	NULL
of	NULL
chronic	NULL
inflammation	NULL
,	NULL
including	NULL
trinitrobenzene	NULL
sulfonic	NULL
acid	NULL
(	NULL
TNBS	NULL
)	NULL
-induced	NULL
colitis	NULL
[	NULL
11	NULL
]	NULL
,	NULL
endotoxemia	NULL
[	NULL
12	NULL
]	NULL
,	NULL
and	NULL
radiation-induced	NULL
thoracic	NULL
injury	NULL
[	NULL
13	NULL
]	NULL
.	NULL

Mice	NULL
transgenically	NULL
overexpress-ing	NULL
IL-11	NULL
in	NULL
lung	NULL
develop	NULL
pulmonary	NULL
lymphocytic	NULL
infiltrates	NULL
,	NULL
airway	NULL
remodeling	NULL
,	NULL
and	NULL
subepithelial	NULL
fibrosis	NULL
[	NULL
14	NULL
]	NULL
.	NULL

In	NULL
the	NULL
current	NULL
studies	NULL
we	NULL
sought	NULL
to	NULL
determine	NULL
the	NULL
physiological	NULL
role	NULL
of	NULL
IL-11	NULL
during	NULL
acute	NULL
lung	NULL
inflammation	NULL
induced	NULL
by	NULL
IgG	NULL
immune	NULL
complexes	NULL
.	NULL

Our	NULL
data	NULL
indicate	NULL
that	NULL
in	NULL
this	NULL
model	NULL
IL-11	NULL
is	NULL
up-regulated	NULL
in	NULL
lung	NULL
at	NULL
both	NULL
the	NULL
mRNA	NULL
and	NULL
protein	NULL
levels	NULL
.	NULL

Exogenous	NULL
administration	NULL
of	NULL
IL-11	NULL
suppresses	NULL
IgG	NULL
immune	NULL
complex-induced	NULL
neutrophil	NULL
accumulation	NULL
and	NULL
lung	NULL
vascular	NULL
permeability	NULL
.	NULL

IL-11	NULL
also	NULL
suppresses	NULL
lung	NULL
NF-KB	NULL
activation	NULL
in	NULL
association	NULL
with	NULL
reduced	NULL
BAL	NULL
levels	NULL
of	NULL
TNF-a	NULL
and	NULL
decreased	NULL
pulmonary	NULL
vascular	NULL
expression	NULL
of	NULL
ICAM-1	NULL
.	NULL

At	NULL
the	NULL
same	NULL
time	NULL
,	NULL
C5a	NULL
levels	NULL
in	NULL
the	NULL
lung	NULL
are	NULL
reduced	NULL
but	NULL
BAL	NULL
levels	NULL
of	NULL
the	NULL
CXC	NULL
chemokines	NULL
,	NULL
MIP-2	NULL
and	NULL
CINC	NULL
,	NULL
are	NULL
unaffected	NULL
.	NULL

These	NULL
data	NULL
indicate	NULL
that	NULL
IL-11	NULL
has	NULL
the	NULL
ability	NULL
to	NULL
regulate	NULL
the	NULL
acute	NULL
lung	NULL
inflammatory	NULL
response	NULL
.	NULL

Abbreviations	NULL
:	NULL
IL-11	NULL
,	NULL
interleukin-11	NULL
;	NULL
TNF-	NULL
@	NULL
,	NULL
tumor	NULL
necrosis	NULL
factor	NULL
a	NULL
;	NULL
BAL	NULL
,	NULL
bronchalveolar	NULL
lavage	NULL
;	NULL
MIP-2	NULL
,	NULL
macrophage	NULL
inflammatory	NULL
protein-2	NULL
;	NULL
CINC	NULL
,	NULL
cytokine-inducible	NULL
neutrophil	NULL
chemoattractant	NULL
;	NULL
TNBS	NULL
,	NULL
trinitrobenzene	NULL
sulfonic	NULL
acid	NULL
;	NULL
BSA	NULL
,	NULL
bovine	NULL
serum	NULL
albumin	NULL
;	NULL
RT-PCR	NULL
,	NULL
reverse	NULL
transcriptase-polymerase	NULL
chain	NULL
reaction	NULL
;	NULL
GAPDH	NULL
,	NULL
glyceraldehyde	NULL
3-phosphate	NULL
dehydrogenase	NULL
;	NULL
EMSA	NULL
,	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
;	NULL
MPO	NULL
,	NULL
myeloperoxidase	NULL
;	NULL
ELISA	NULL
,	NULL
enzyme-linked	NULL
immunosorbent	NULL
assay	NULL
.	NULL

Correspondence	NULL
:	NULL
Alex	NULL
B.	NULL
Lentsch	NULL
,	NULL
Ph.D.	NULL
,	NULL
Department	NULL
of	NULL
Surgery	NULL
,	NULL
University	NULL
of	NULL
Louisville	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
J.G	NULL
.	NULL

Brown	NULL
Cancer	NULL
Center	NULL
,	NULL
Rm	NULL
.	NULL

426	NULL
,	NULL
529	NULL
South	NULL
Jackson	NULL
Street	NULL
,	NULL
Louisville	NULL
,	NULL
KY	NULL
40202	NULL
.	NULL

E-mail	NULL
:	NULL
ablent01	NULL
@	NULL
ulkyym.louisville.edu	NULL
Received	NULL
January	NULL
14	NULL
,	NULL
1999	NULL
;	NULL
accepted	NULL
March	NULL
10	NULL
,	NULL
1999	NULL
.	NULL

Journal	NULL
of	NULL
Leukocyte	NULL
Biology	NULL
Volume	NULL
66	NULL
,	NULL
July	NULL
1999	NULL
151	NULL
METHODS	NULL
Reagents	NULL
Human	NULL
recombinant	NULL
IL-11	NULL
and	NULL
mouse	NULL
monoclonal	NULL
IgG1	NULL
anti-human	NULL
IL-11	NULL
(	NULL
clone	NULL
11h3/19.6.1	NULL
)	NULL
were	NULL
gifts	NULL
from	NULL
Genetics	NULL
Institute	NULL
,	NULL
Inc.	NULL
(	NULL
Cambridge	NULL
,	NULL
MA	NULL
)	NULL
.	NULL

Mouse	NULL
monoclonal	NULL
IgG1	NULL
anti-rat	NULL
ICAM-1	NULL
(	NULL
clone	NULL
1A29	NULL
)	NULL
was	NULL
purchased	NULL
from	NULL
PharMingen	NULL
,	NULL
Inc.	NULL
(	NULL
San	NULL
Diego	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Irrelevant	NULL
mouse	NULL
IgG1	NULL
(	NULL
clone	NULL
MOPC-21	NULL
)	NULL
was	NULL
purchased	NULL
from	NULL
ICN	NULL
Biomedicals	NULL
,	NULL
Inc.	NULL
(	NULL
Costa	NULL
Mesa	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

All	NULL
other	NULL
reagents	NULL
,	NULL
unless	NULL
otherwise	NULL
indicated	NULL
,	NULL
were	NULL
purchased	NULL
from	NULL
Sigma	NULL
(	NULL
St.	NULL
Louis	NULL
,	NULL
MO	NULL
)	NULL
.	NULL

IgG	NULL
immune	NULL
complex-induced	NULL
alveolitis	NULL
Pathogen-free	NULL
male	NULL
Long-Eivans	NULL
rats	NULL
(	NULL
275-300	NULL
g	NULL
;	NULL
Harlan	NULL
Sprague-Dawley	NULL
,	NULL
Indianapolis	NULL
,	NULL
IN	NULL
)	NULL
were	NULL
anesthetized	NULL
with	NULL
ketamine	NULL
HCl	NULL
(	NULL
150	NULL
mg/kg	NULL
,	NULL
intraperito-neally	NULL
)	NULL
.	NULL

Rats	NULL
received	NULL
intratracheal	NULL
administration	NULL
of	NULL
1.5	NULL
mg	NULL
antibody	NULL
to	NULL
bovine	NULL
serum	NULL
albumin	NULL
(	NULL
anti-BSA	NULL
;	NULL
ICN	NULL
Biomedicals	NULL
,	NULL
Inc.	NULL
)	NULL
in	NULL
a	NULL
volume	NULL
of	NULL
0.3	NULL
mL	NULL
phosphate-buffered	NULL
saline	NULL
(	NULL
PBS	NULL
)	NULL
.	NULL

Negative	NULL
control	NULL
rats	NULL
received	NULL
intratracheal	NULL
administration	NULL
of	NULL
PBS	NULL
,	NULL
pH	NULL
7.4	NULL
.	NULL

Immediately	NULL
thereafter	NULL
,	NULL
10	NULL
mg	NULL
BSA	NULL
(	NULL
<	NULL
1	NULL
ng	NULL
endotoxin/mg	NULL
)	NULL
in	NULL
0.5	NULL
mL	NULL
PBS	NULL
was	NULL
injected	NULL
intravenously	NULL
.	NULL

For	NULL
analysis	NULL
of	NULL
pulmonary	NULL
vascular	NULL
permeability	NULL
,	NULL
trace	NULL
amounts	NULL
of	NULL
'*	NULL
``	NULL
I-labeled	NULL
BSA	NULL
were	NULL
injected	NULL
intravenously	NULL
.	NULL

Four	NULL
hours	NULL
after	NULL
IgG	NULL
immune	NULL
complex	NULL
deposition	NULL
,	NULL
rats	NULL
were	NULL
exsanguinated	NULL
,	NULL
the	NULL
pulmonary	NULL
circulation	NULL
was	NULL
flushed	NULL
with	NULL
10	NULL
mL	NULL
PBS	NULL
by	NULL
pulmonary	NULL
artery	NULL
injection	NULL
,	NULL
and	NULL
the	NULL
lungs	NULL
surgically	NULL
removed	NULL
.	NULL

The	NULL
extent	NULL
of	NULL
Tung	NULL
injury	NULL
was	NULL
quantified	NULL
by	NULL
calculating	NULL
the	NULL
lung	NULL
permeability	NULL
index	NULL
[	NULL
dividing	NULL
the	NULL
amount	NULL
of	NULL
radioactivity	NULL
(	NULL
'**I-labeled	NULL
BSA	NULL
)	NULL
in	NULL
the	NULL
perfused	NULL
lungs	NULL
by	NULL
the	NULL
amount	NULL
of	NULL
radioactivity	NULL
in	NULL
1.0	NULL
mL	NULL
of	NULL
blood	NULL
obtained	NULL
from	NULL
the	NULL
inferior	NULL
vena	NULL
cava	NULL
at	NULL
the	NULL
time	NULL
of	NULL
death	NULL
]	NULL
.	NULL

For	NULL
measurement	NULL
of	NULL
lung	NULL
NF-KB	NULL
activation	NULL
,	NULL
lungs	NULL
were	NULL
surgically	NULL
dissected	NULL
and	NULL
immediately	NULL
frozen	NULL
in	NULL
liquid	NULL
nitrogen	NULL
.	NULL

Reverse	NULL
transcription-polymerase	NULL
chain	NULL
reaction	NULL
(	NULL
RT-PCR	NULL
)	NULL
Total	NULL
RNA	NULL
from	NULL
whole	NULL
lung	NULL
tissue	NULL
was	NULL
extracted	NULL
using	NULL
a	NULL
guanidinium-isothiocyanate	NULL
method	NULL
as	NULL
described	NULL
previously	NULL
[	NULL
15	NULL
]	NULL
.	NULL

Total	NULL
RNA	NULL
(	NULL
20	NULL
ng	NULL
)	NULL
was	NULL
reverse	NULL
transcribed	NULL
to	NULL
cDNA	NULL
.	NULL

The	NULL
cDNA	NULL
products	NULL
were	NULL
amplified	NULL
by	NULL
PCR	NULL
(	NULL
85	NULL
cycles	NULL
;	NULL
1	NULL
min	NULL
each	NULL
at	NULL
95	NULL
,	NULL
55	NULL
,	NULL
and	NULL
72°C	NULL
)	NULL
.	NULL

The	NULL
5	NULL
'	NULL
primer	NULL
(	NULL
5	NULL
-ATGAACTGTGTTT-GTCGCCTG-3	NULL
'	NULL
)	NULL
and	NULL
3	NULL
'	NULL
primer	NULL
(	NULL
6	NULL
'-GTTGTTAAAGACTCGACTGTG-3	NULL
'	NULL
)	NULL
were	NULL
complementary	NULL
to	NULL
5	NULL
'	NULL
and	NULL
3	NULL
'	NULL
regions	NULL
of	NULL
the	NULL
open	NULL
reading	NULL
frame	NULL
of	NULL
the	NULL
human	NULL
IL-11	NULL
sequence	NULL
.	NULL

PCR	NULL
products	NULL
were	NULL
sequenced	NULL
for	NULL
verification	NULL
.	NULL

RT-PCR	NULL
of	NULL
the	NULL
glyceraldehyde	NULL
3-phosphate	NULL
dehydrogenase	NULL
(	NULL
GAPDH	NULL
)	NULL
cDNA	NULL
was	NULL
performed	NULL
(	NULL
5	NULL
'	NULL
primer	NULL
,	NULL
5'-TCACCATCTTCCAG	NULL
GAGC-8	NULL
'	NULL
;	NULL
3	NULL
``	NULL
primer	NULL
,	NULL
5'-CTGCTTCAC-CACCTTCTTGA-3	NULL
'	NULL
)	NULL
under	NULL
the	NULL
same	NULL
conditions	NULL
described	NULL
above	NULL
to	NULL
confirm	NULL
equal	NULL
loading	NULL
of	NULL
RNA	NULL
.	NULL

PCR	NULL
products	NULL
were	NULL
electrophoresed	NULL
in	NULL
a	NULL
1	NULL
%	NULL
agarose	NULL
gel	NULL
and	NULL
stained	NULL
with	NULL
ethidium	NULL
bromide	NULL
.	NULL

Photographs	NULL
of	NULL
PCR	NULL
products	NULL
were	NULL
digitized	NULL
and	NULL
analyzed	NULL
using	NULL
image	NULL
analysis	NULL
software	NULL
(	NULL
Adobe	NULL
Systems	NULL
,	NULL
San	NULL
Jose	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Western	NULL
blot	NULL
analysis	NULL
BAL	NULL
fluids	NULL
were	NULL
concentrated	NULL
approximately	NULL
100-fold	NULL
and	NULL
40	NULL
nL	NULL
were	NULL
separated	NULL
in	NULL
a	NULL
denaturing	NULL
15	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
and	NULL
transferred	NULL
to	NULL
a	NULL
0.1-um-pore	NULL
nitrocellulose	NULL
membrane	NULL
.	NULL

Nonspecific	NULL
binding	NULL
sites	NULL
were	NULL
blocked	NULL
with	NULL
TBS	NULL
(	NULL
40	NULL
mM	NULL
Tris	NULL
,	NULL
pH	NULL
7.6	NULL
,	NULL
300	NULL
mM	NULL
NaCl	NULL
)	NULL
containing	NULL
5	NULL
%	NULL
nonfat	NULL
dry	NULL
milk	NULL
for	NULL
12	NULL
h	NULL
at	NULL
4°C	NULL
.	NULL

Membranes	NULL
were	NULL
then	NULL
incubated	NULL
in	NULL
monoclonal	NULL
mouse	NULL
IgG	NULL
anti-IL-11	NULL
(	NULL
2	NULL
pg/mL	NULL
)	NULL
in	NULL
TBS	NULL
with	NULL
0.1	NULL
%	NULL
Tween	NULL
20	NULL
(	NULL
TBST	NULL
)	NULL
.	NULL

After	NULL
three	NULL
washes	NULL
in	NULL
TBST	NULL
,	NULL
membranes	NULL
were	NULL
incubated	NULL
in	NULL
a	NULL
1:10,000	NULL
dilution	NULL
of	NULL
horseradish	NULL
peroxidase-conjugated	NULL
sheep	NULL
anti-mouse	NULL
IgG	NULL
(	NULL
Amersham	NULL
,	NULL
Arlington	NULL
Heights	NULL
,	NULL
IL	NULL
)	NULL
.	NULL

Immunoreactive	NULL
proteins	NULL
were	NULL
detected	NULL
by	NULL
enhanced	NULL
chemiluminescence	NULL
.	NULL

NF-KB	NULL
activation	NULL
by	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
(	NULL
EMSA	NULL
)	NULL
Nuclear	NULL
extracts	NULL
of	NULL
whole	NULL
lung	NULL
tissues	NULL
were	NULL
prepared	NULL
by	NULL
the	NULL
method	NULL
of	NULL
Deryckere	NULL
and	NULL
Gannon	NULL
[	NULL
16	NULL
]	NULL
.	NULL

Protein	NULL
concentrations	NULL
were	NULL
determined	NULL
by	NULL
bicinchoninic	NULL
acid	NULL
assay	NULL
with	NULL
trichloroacetic	NULL
acid	NULL
precipitation	NULL
using	NULL
BSA	NULL
as	NULL
a	NULL
reference	NULL
standard	NULL
(	NULL
Pierce	NULL
,	NULL
Rockford	NULL
,	NULL
IL	NULL
)	NULL
.	NULL

Double-stranded	NULL
NF-KB	NULL
consensus	NULL
oligonucleotide	NULL
(	NULL
5'-AGTGAGGGGACTTTCCCAGGC-3	NULL
'	NULL
;	NULL
Promega	NULL
,	NULL
Madison	NULL
,	NULL
WI	NULL
)	NULL
was	NULL
end-labeled	NULL
with	NULL
[	NULL
y-*	NULL
``	NULL
PJATP	NULL
(	NULL
3,000	NULL
Ci/mmol	NULL
at	NULL
10	NULL
mCi/mL	NULL
,	NULL
Amer-	NULL
152	NULL
-	NULL
Journal	NULL
of	NULL
Leukocyte	NULL
Biology	NULL
Volume	NULL
66	NULL
,	NULL
July	NULL
1999	NULL
sham	NULL
)	NULL
.	NULL

Binding	NULL
reactions	NULL
containing	NULL
equal	NULL
amounts	NULL
of	NULL
protein	NULL
(	NULL
10	NULL
ug	NULL
)	NULL
and	NULL
85	NULL
fmol	NULL
(	NULL
~50,000	NULL
cpm	NULL
,	NULL
Cherenkov	NULL
counting	NULL
)	NULL
of	NULL
oligonucleotide	NULL
were	NULL
performed	NULL
for	NULL
30	NULL
min	NULL
in	NULL
binding	NULL
buffer	NULL
(	NULL
4	NULL
%	NULL
glycerol	NULL
,	NULL
1	NULL
mM	NULL
0.5	NULL
mM	NULL
EDTA	NULL
,	NULL
pH	NULL
8.0	NULL
,	NULL
0.5	NULL
mM	NULL
dithiothreitol	NULL
,	NULL
50	NULL
mM	NULL
NaCl	NULL
,	NULL
10	NULL
mM	NULL
Tris	NULL
,	NULL
pH	NULL
7.6	NULL
,	NULL
50	NULL
pg/mL	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
;	NULL
Pharmacia	NULL
,	NULL
Piscataway	NULL
,	NULL
NJ	NULL
)	NULL
.	NULL

Reaction	NULL
volumes	NULL
were	NULL
held	NULL
constant	NULL
at	NULL
15	NULL
uL	NULL
.	NULL

Reaction	NULL
products	NULL
were	NULL
separated	NULL
in	NULL
a	NULL
4	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
and	NULL
analyzed	NULL
by	NULL
autoradiography	NULL
.	NULL

NF-KB	NULL
activation	NULL
was	NULL
quantitated	NULL
from	NULL
digitized	NULL
autoradiography	NULL
films	NULL
using	NULL
image	NULL
analysis	NULL
software	NULL
(	NULL
Adobe	NULL
Systems	NULL
)	NULL
.	NULL

Lung	NULL
vascular	NULL
expression	NULL
of	NULL
ICAM-1	NULL
Rats	NULL
were	NULL
injected	NULL
intravenously	NULL
with	NULL
1.5	NULL
uCi	NULL
of	NULL
'*	NULL
``	NULL
I-labeled	NULL
anti-ICAM-1	NULL
3.75	NULL
h	NULL
after	NULL
induction	NULL
of	NULL
lung	NULL
injury	NULL
.	NULL

The	NULL
specific	NULL
activity	NULL
of	NULL
the	NULL
anti-ICAM-1	NULL
was	NULL
11.3	NULL
uCi/ng	NULL
.	NULL

Fifteen	NULL
minutes	NULL
later	NULL
(	NULL
4	NULL
h	NULL
after	NULL
induction	NULL
of	NULL
lung	NULL
injury	NULL
)	NULL
,	NULL
rats	NULL
were	NULL
killed	NULL
and	NULL
the	NULL
lung	NULL
vasculature	NULL
was	NULL
flushed	NULL
with	NULL
10	NULL
mL	NULL
PBS	NULL
.	NULL

Lung	NULL
vascular	NULL
ICAM-1	NULL
expression	NULL
(	NULL
binding	NULL
index	NULL
)	NULL
was	NULL
calculated	NULL
by	NULL
dividing	NULL
the	NULL
amount	NULL
of	NULL
radioactivity	NULL
(	NULL
``	NULL
I-labeled	NULL
antibody	NULL
)	NULL
in	NULL
perfused	NULL
lungs	NULL
by	NULL
the	NULL
amount	NULL
of	NULL
radioactivity	NULL
in	NULL
1.0	NULL
mL	NULL
of	NULL
blood	NULL
.	NULL

To	NULL
control	NULL
for	NULL
nonspecific	NULL
binding	NULL
and	NULL
potential	NULL
accumulation	NULL
of	NULL
anti-ICAM-1	NULL
antibody	NULL
in	NULL
lung	NULL
parenchyma	NULL
due	NULL
to	NULL
injury	NULL
,	NULL
1.5	NULL
nCi	NULL
of	NULL
'*	NULL
``	NULL
I-labeled	NULL
nonspecific	NULL
mouse	NULL
IgG1	NULL
were	NULL
administered	NULL
in	NULL
a	NULL
separate	NULL
set	NULL
of	NULL
rats	NULL
undergoing	NULL
IgG	NULL
immune	NULL
complex	NULL
lung	NULL
injury	NULL
.	NULL

The	NULL
specific	NULL
activity	NULL
of	NULL
the	NULL
irrelevant	NULL
IgG	NULL
antibody	NULL
was	NULL
13.0	NULL
uCi/ug	NULL
.	NULL

This	NULL
technique	NULL
has	NULL
been	NULL
described	NULL
in	NULL
detail	NULL
elsewhere	NULL
[	NULL
17	NULL
]	NULL
.	NULL

Lung	NULL
myeloperoxidase	NULL
(	NULL
MPO	NULL
)	NULL
content	NULL
Whole-lung	NULL
MPO	NULL
activity	NULL
was	NULL
quantitated	NULL
as	NULL
described	NULL
previously	NULL
[	NULL
18	NULL
]	NULL
.	NULL

Briefly	NULL
,	NULL
whole	NULL
lungs	NULL
homogenates	NULL
were	NULL
diluted	NULL
in	NULL
50	NULL
mM	NULL
potassium	NULL
phosphate	NULL
buffer	NULL
containing	NULL
0.5	NULL
%	NULL
hexadecyltrimethylammonium	NULL
bromide	NULL
,	NULL
pH	NULL
6.0	NULL
.	NULL

After	NULL
sonica-tion	NULL
and	NULL
two	NULL
freeze-thaw	NULL
cycles	NULL
,	NULL
samples	NULL
were	NULL
centrifuged	NULL
at	NULL
4000	NULL
g	NULL
for	NULL
30	NULL
min	NULL
.	NULL

The	NULL
supernatants	NULL
were	NULL
reacted	NULL
with	NULL
HO	NULL
,	NULL
(	NULL
0.3	NULL
mM	NULL
)	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
tetramethylbenzidine	NULL
(	NULL
1.6	NULL
mM	NULL
)	NULL
.	NULL

MPO	NULL
activity	NULL
was	NULL
assessed	NULL
by	NULL
measuring	NULL
the	NULL
change	NULL
in	NULL
absorbance	NULL
at	NULL
655	NULL
nm	NULL
.	NULL

BAL	NULL
fluid	NULL
neutrophil	NULL
and	NULL
cytokine	NULL
content	NULL
BAL	NULL
fluids	NULL
were	NULL
collected	NULL
by	NULL
instilling	NULL
and	NULL
withdrawing	NULL
5	NULL
mL	NULL
of	NULL
sterile	NULL
PBS	NULL
three	NULL
times	NULL
from	NULL
the	NULL
lungs	NULL
via	NULL
an	NULL
intratracheal	NULL
cannula	NULL
.	NULL

Cellular	NULL
contents	NULL
were	NULL
recovered	NULL
by	NULL
centrifugation	NULL
and	NULL
neutrophils	NULL
were	NULL
counted	NULL
by	NULL
microcytometry	NULL
.	NULL

BAL	NULL
content	NULL
of	NULL
TNF-	NULL
was	NULL
measured	NULL
using	NULL
a	NULL
standard	NULL
WEHI	NULL
cell	NULL
cytotoxicity	NULL
assay	NULL
as	NULL
previously	NULL
reported	NULL
[	NULL
19	NULL
]	NULL
.	NULL

Measurement	NULL
of	NULL
CINC	NULL
,	NULL
macrophage	NULL
inflammatory	NULL
protein-2	NULL
(	NULL
MIP-2	NULL
)	NULL
,	NULL
and	NULL
C5a	NULL
in	NULL
BAL	NULL
fluids	NULL
was	NULL
by	NULL
enzyme-linked	NULL
immunosorbent	NULL
assay	NULL
(	NULL
ELISA	NULL
)	NULL
as	NULL
described	NULL
elsewhere	NULL
[	NULL
20	NULL
,	NULL
21	NULL
]	NULL
.	NULL

Statistical	NULL
analyses	NULL
All	NULL
values	NULL
are	NULL
expressed	NULL
as	NULL
means	NULL
~	NULL
SEM	NULL
.	NULL

Data	NULL
were	NULL
analyzed	NULL
with	NULL
a	NULL
one-way	NULL
analysis	NULL
of	NULL
variance	NULL
and	NULL
individual	NULL
group	NULL
means	NULL
were	NULL
then	NULL
compared	NULL
with	NULL
a	NULL
Student-	NULL
Newman-Keuls	NULL
test	NULL
Differences	NULL
were	NULL
considered	NULL
significant	NULL
when	NULL
P	NULL
<	NULL
0.05	NULL
.	NULL

For	NULL
calculations	NULL
of	NULL
percent	NULL
change	NULL
,	NULL
negative	NULL
control	NULL
values	NULL
were	NULL
subtracted	NULL
from	NULL
positive	NULL
control	NULL
and	NULL
treatment	NULL
group	NULL
values	NULL
.	NULL

RESULTS	NULL
Pulmonary	NULL
expression	NULL
of	NULL
IL-11	NULL
during	NULL
IgG	NULL
immune	NULL
complex	NULL
alveolitis	NULL
Expression	NULL
of	NULL
IL-11	NULL
mRNA	NULL
in	NULL
lung	NULL
extracts	NULL
from	NULL
rats	NULL
undergoing	NULL
IgG	NULL
immune	NULL
complex-induced	NULL
lung	NULL
injury	NULL
was	NULL
determined	NULL
by	NULL
RT-PCR	NULL
.	NULL

IL-11	NULL
mRNA	NULL
was	NULL
constitutively	NULL
expressed	NULL
at	NULL
very	NULL
low	NULL
levels	NULL
in	NULL
lung	NULL
,	NULL
the	NULL
RT-PCR	NULL
product	NULL
being	NULL
present	NULL
at	NULL
the	NULL
initiation	NULL
of	NULL
lung	NULL
injury	NULL
(	NULL
time	NULL
0	NULL
;	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

IL-11	NULL
mRNA	NULL
expression	NULL
increased	NULL
30	NULL
min	NULL
after	NULL
intrapulmonary	NULL
deposition	NULL
of	NULL
IgG	NULL
immune	NULL
complexes	NULL
,	NULL
reaching	NULL
a	NULL
maximal	NULL
level	NULL
after	NULL
1	NULL
h	NULL
,	NULL
declining	NULL
at	NULL
2	NULL
h	NULL
,	NULL
and	NULL
returning	NULL
to	NULL
baseline	NULL
4	NULL
h	NULL
after	NULL
initiation	NULL
of	NULL
injury	NULL
.	NULL

In	NULL
accordance	NULL
with	NULL
IL-11	NULL
mRNA	NULL
,	NULL
IL-11	NULL
protein	NULL
was	NULL
constitutively	NULL
expressed	NULL
at	NULL
low	NULL
levels	NULL
in	NULL
lung	NULL
before	NULL
initiation	NULL
of	NULL
http	NULL
:	NULL
//www.jleukbi0.org	NULL
A	NULL
Time	NULL
(	NULL
hours	NULL
)	NULL
0	NULL
0	NULL
050	NULL
4	NULL
-	NULL
2004	NULL
IL-11	NULL
ie	NULL
*	NULL
200	NULL
150	NULL
7	NULL
100	NULL
7	NULL
50	NULL
-I	NULL
IL-11	NULL
mRNA	NULL
Expression	NULL
(	NULL
relative	NULL
intensity	NULL
units	NULL
)	NULL
Time	NULL
(	NULL
hours	NULL
)	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

Expression	NULL
of	NULL
rat	NULL
IL-11	NULL
mRNA	NULL
during	NULL
IgG	NULL
immune	NULL
complex	NULL
alveolitis	NULL
.	NULL

Lung	NULL
RNA	NULL
extracts	NULL
were	NULL
analyzed	NULL
by	NULL
RT-PCR	NULL
(	NULL
A	NULL
)	NULL
and	NULL
ethidium	NULL
bromide-stained	NULL
PCR	NULL
products	NULL
were	NULL
digitized	NULL
using	NULL
image	NULL
analysis	NULL
(	NULL
B	NULL
)	NULL
.	NULL

Equal	NULL
loading	NULL
of	NULL
RNA	NULL
was	NULL
confirmed	NULL
by	NULL
RT-PCR	NULL
of	NULL
the	NULL
housekeeping	NULL
gene	NULL
,	NULL
GAPDH	NULL
.	NULL

Results	NULL
are	NULL
representative	NULL
of	NULL
three	NULL
independent	NULL
experiments	NULL
.	NULL

the	NULL
lung	NULL
inflammatory	NULL
reaction	NULL
.	NULL

Western	NULL
blot	NULL
analysis	NULL
of	NULL
concentrated	NULL
BAL	NULL
fluids	NULL
demonstrated	NULL
barely	NULL
detectable	NULL
levels	NULL
of	NULL
IL-11	NULL
protein	NULL
at	NULL
the	NULL
initiation	NULL
of	NULL
lung	NULL
injury	NULL
(	NULL
time	NULL
0	NULL
;	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

Expression	NULL
of	NULL
IL-11	NULL
protein	NULL
was	NULL
markedly	NULL
increased	NULL
1	NULL
h	NULL
after	NULL
IgG	NULL
immune	NULL
complex	NULL
deposition	NULL
and	NULL
further	NULL
increases	NULL
were	NULL
detected	NULL
at	NULL
2	NULL
and	NULL
4	NULL
h.	NULL
Effects	NULL
of	NULL
exogenous	NULL
IL-11	NULL
on	NULL
IgG	NULL
immune	NULL
complex-induced	NULL
neutrophil	NULL
accumulation	NULL
and	NULL
lung	NULL
injury	NULL
Experiments	NULL
were	NULL
designed	NULL
to	NULL
assess	NULL
the	NULL
effects	NULL
of	NULL
exogenously	NULL
administered	NULL
recombinant	NULL
human	NULL
IL-11	NULL
on	NULL
lung	NULL
vascular	NULL
permeability	NULL
and	NULL
lung	NULL
neutrophil	NULL
recruitment	NULL
in	NULL
the	NULL
IgG	NULL
immune	NULL
complex	NULL
model	NULL
of	NULL
lung	NULL
injury	NULL
.	NULL

The	NULL
extent	NULL
of	NULL
lung	NULL
injury	NULL
was	NULL
determined	NULL
by	NULL
extravascular	NULL
leakage	NULL
of	NULL
albumin	NULL
.	NULL

Intrapulmonary	NULL
deposition	NULL
of	NULL
IgG	NULL
immune	NULL
complexes	NULL
caused	NULL
a	NULL
threefold	NULL
increase	NULL
in	NULL
the	NULL
lung	NULL
permeability	NULL
index	NULL
(	NULL
Fig	NULL
.	NULL

3A	NULL
)	NULL
.	NULL

Time	NULL
(	NULL
h	NULL
)	NULL
std	NULL
O0	NULL
-	NULL
1	NULL
2	NULL
4	NULL
m-	NULL
tons	NULL
-ef	NULL
»	NULL
|	NULL
«	NULL
Fig	NULL
.	NULL

2	NULL
.	NULL

BAL	NULL
fluid	NULL
content	NULL
of	NULL
IL-11	NULL
protein	NULL
during	NULL
IgG	NULL
immune	NULL
complex	NULL
alveolitis	NULL
.	NULL

BAL	NULL
fluids	NULL
were	NULL
concentrated	NULL
(	NULL
100-fold	NULL
)	NULL
and	NULL
40	NULL
L	NULL
were	NULL
analyzed	NULL
by	NULL
Western	NULL
blot	NULL
.	NULL

Recombinant	NULL
human	NULL
IL-11	NULL
was	NULL
used	NULL
as	NULL
a	NULL
reference	NULL
standard	NULL
(	NULL
std	NULL
)	NULL
in	NULL
the	NULL
extreme	NULL
left	NULL
lane	NULL
.	NULL

Results	NULL
are	NULL
representative	NULL
of	NULL
two	NULL
independent	NULL
experiments	NULL
.	NULL

Intratracheal	NULL
administration	NULL
of	NULL
IL-11	NULL
(	NULL
administered	NULL
with	NULL
the	NULL
anti-BSA	NULL
)	NULL
caused	NULL
a	NULL
dose-dependent	NULL
reduction	NULL
in	NULL
the	NULL
lung	NULL
permeability	NULL
index	NULL
.	NULL

In	NULL
the	NULL
presence	NULL
of	NULL
10	NULL
,	NULL
30	NULL
,	NULL
or	NULL
60	NULL
pg	NULL
IL-11	NULL
,	NULL
the	NULL
permeability	NULL
index	NULL
was	NULL
reduced	NULL
29	NULL
%	NULL
(	NULL
P	NULL
,	NULL
NS	NULL
)	NULL
,	NULL
43	NULL
%	NULL
(	NULL
P	NULL
,	NULL
NS	NULL
)	NULL
and	NULL
66	NULL
%	NULL
(	NULL
P	NULL
<	NULL
0.05	NULL
)	NULL
,	NULL
respectively	NULL
.	NULL

To	NULL
assess	NULL
whether	NULL
the	NULL
protective	NULL
effects	NULL
of	NULL
IL-11	NULL
were	NULL
related	NULL
to	NULL
reduced	NULL
pulmonary	NULL
recruitment	NULL
of	NULL
neutrophils	NULL
,	NULL
lung	NULL
MPO	NULL
content	NULL
and	NULL
the	NULL
number	NULL
of	NULL
neutrophils	NULL
in	NULL
BAL	NULL
fluids	NULL
were	NULL
determined	NULL
.	NULL

Treatment	NULL
with	NULL
IL-11	NULL
caused	NULL
dose-dependent	NULL
decreases	NULL
in	NULL
lung	NULL
MPO	NULL
content	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
.	NULL

Intratracheal	NULL
administration	NULL
of	NULL
10	NULL
,	NULL
30	NULL
,	NULL
or	NULL
60	NULL
ug	NULL
IL-11	NULL
reduced	NULL
lung	NULL
MPO	NULL
content	NULL
by	NULL
12	NULL
%	NULL
(	NULL
P	NULL
,	NULL
NS	NULL
)	NULL
,	NULL
58	NULL
%	NULL
(	NULL
P	NULL
<	NULL
0.05	NULL
)	NULL
,	NULL
and	NULL
67	NULL
%	NULL
(	NULL
P	NULL
<	NULL
0.05	NULL
)	NULL
,	NULL
respectively	NULL
.	NULL

Similarly	NULL
,	NULL
60	NULL
pg	NULL
IL-11	NULL
decreased	NULL
the	NULL
number	NULL
of	NULL
neutrophils	NULL
present	NULL
in	NULL
BAL	NULL
fluids	NULL
from	NULL
65.9	NULL
+-	NULL
3.5	NULL
X	NULL
10°	NULL
cells/mL	NULL
in	NULL
positive	NULL
controls	NULL
to	NULL
22.0	NULL
+	NULL
3.6	NULL
X	NULL
10°	NULL
cells/mL	NULL
,	NULL
a	NULL
reduction	NULL
of	NULL
67	NULL
%	NULL
(	NULL
P	NULL
<	NULL
0.05	NULL
)	NULL
.	NULL

A	NULL
--	NULL
]	NULL
negative	NULL
control	NULL
0.8	NULL
-	NULL
positive	NULL
control	NULL
as	NULL
66	NULL
%	NULL
de	NULL
%	NULL
decrease	NULL
O	NULL
064	NULL
_—|—_	NULL
p	NULL
<	NULL
0.05	NULL
£	NULL
_L	NULL
2	NULL
«	NULL
<	NULL
.	NULL

E	NULL
0.4	NULL
m	NULL
_L	NULL
®	NULL
E	NULL
or	NULL
]	NULL
|-0	NULL
a	NULL
.	NULL

0.0	NULL
T	NULL
I	NULL
U	NULL
T	NULL
t	NULL
1	NULL
0	NULL
0	NULL
10	NULL
30	NULL
60	NULL
IL-11	NULL
(	NULL
ug	NULL
)	NULL
B	NULL
2.0	NULL
-po-	NULL
sso	NULL
0	NULL
_	NULL
-C	NULL
E	NULL
1.5	NULL
58	NULL
%	NULL
decrease	NULL
0	NULL
p	NULL
<	NULL
0.05	NULL
o	NULL
g	NULL
Gmpigfggase	NULL
0	NULL
$	NULL
i0-ss	NULL
C	NULL
2	NULL
-	NULL
os-al	NULL
A	NULL
~I-	NULL
\	NULL
0.0	NULL
t	NULL
t	NULL
f	NULL
1	NULL
0	NULL
=	NULL
0	NULL
=	NULL
10	NULL
_	NULL
so	NULL
_	NULL
60	NULL
IL-11	NULL
(	NULL
ug	NULL
)	NULL
Fig	NULL
.	NULL

3	NULL
.	NULL

Effects	NULL
of	NULL
IL-11	NULL
on	NULL
IgG	NULL
immune	NULL
complex-induced	NULL
lung	NULL
vascular	NULL
permeability	NULL
(	NULL
A	NULL
)	NULL
and	NULL
lung	NULL
neutrophil	NULL
accumulation	NULL
(	NULL
B	NULL
)	NULL
.	NULL

Permeability	NULL
index	NULL
(	NULL
n	NULL
=	NULL
5-9	NULL
)	NULL
and	NULL
lung	NULL
MPO	NULL
content	NULL
(	NULL
r	NULL
=	NULL
3-7	NULL
)	NULL
were	NULL
assessed	NULL
4	NULL
h	NULL
after	NULL
intratracheal	NULL
administration	NULL
of	NULL
1.5	NULL
mg	NULL
anti-BSA	NULL
followed	NULL
by	NULL
intravenous	NULL
infusion	NULL
of	NULL
10	NULL
mg	NULL
BSA	NULL
.	NULL

IL-11	NULL
was	NULL
administered	NULL
intratracheally	NULL
with	NULL
the	NULL
IgG	NULL
anti-BSA	NULL
.	NULL

Values	NULL
represent	NULL
mean	NULL
+	NULL
sEM	NULL
.	NULL

Lentsch	NULL
et	NULL
al	NULL
.	NULL

-	NULL
Regulatory	NULL
effects	NULL
of	NULL
IL-11	NULL
153	NULL
Effects	NULL
of	NULL
IL-11	NULL
on	NULL
lung	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
In	NULL
the	NULL
IgG	NULL
immune	NULL
complex	NULL
model	NULL
,	NULL
development	NULL
of	NULL
lung	NULL
inflammatory	NULL
injury	NULL
is	NULL
associated	NULL
with	NULL
a	NULL
progressive	NULL
increase	NULL
in	NULL
lung	NULL
NF-KB	NULL
activation	NULL
as	NULL
defined	NULL
by	NULL
nuclear	NULL
translocation	NULL
of	NULL
NF-KB	NULL
[	NULL
9	NULL
]	NULL
.	NULL

In	NULL
vitro	NULL
studies	NULL
have	NULL
shown	NULL
that	NULL
IL-11	NULL
suppresses	NULL
NF-KB	NULL
activation	NULL
in	NULL
macrophages	NULL
[	NULL
10	NULL
]	NULL
.	NULL

Therefore	NULL
,	NULL
to	NULL
investigate	NULL
whether	NULL
the	NULL
protective	NULL
effects	NULL
of	NULL
IL-11	NULL
might	NULL
be	NULL
related	NULL
to	NULL
inhibition	NULL
of	NULL
pulmonary	NULL
NF-KB	NULL
activation	NULL
,	NULL
nuclear	NULL
extracts	NULL
from	NULL
whole	NULL
lungs	NULL
harvested	NULL
4	NULL
h	NULL
after	NULL
IgG	NULL
immune	NULL
complex	NULL
deposition	NULL
were	NULL
analyzed	NULL
by	NULL
EMSA	NULL
.	NULL

Little	NULL
NF-KB	NULL
was	NULL
present	NULL
in	NULL
lung	NULL
nuclei	NULL
from	NULL
rats	NULL
treated	NULL
intratracheally	NULL
with	NULL
PBS	NULL
(	NULL
negative	NULL
control	NULL
,	NULL
Fig	NULL
.	NULL

4A	NULL
)	NULL
.	NULL

As	NULL
expected	NULL
,	NULL
intrapulmonary	NULL
deposition	NULL
of	NULL
IgG	NULL
immune	NULL
complexes	NULL
caused	NULL
a	NULL
significant	NULL
increase	NULL
in	NULL
nuclear	NULL
translocation	NULL
of	NULL
NF-KB	NULL
.	NULL

Image	NULL
analysis	NULL
of	NULL
digitized	NULL
EMSA	NULL
blots	NULL
demonstrated	NULL
that	NULL
,	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
10	NULL
,	NULL
A	NULL
IgG-IC	NULL
:	NULL
-	NULL
to	NULL
t+	NULL
0+	NULL
+	NULL
IL-11	NULL
(	NULL
ug	NULL
)	NULL
:	NULL
O	NULL
_	NULL
0	NULL
10	NULL
30	NULL
60	NULL
C	NULL
--	NULL
negative	NULL
control	NULL
Es	NULL
positive	NULL
control	NULL
250	NULL
200	NULL
150	NULL
4	NULL
NF-	NULL
«	NULL
B	NULL
Activation	NULL
(	NULL
relative	NULL
intensity	NULL
units	NULL
)	NULL
100	NULL
IL-11	NULL
(	NULL
ug	NULL
)	NULL
Fig	NULL
.	NULL

4	NULL
.	NULL

Effects	NULL
of	NULL
exogenously	NULL
administered	NULL
recombinant	NULL
human	NULL
IL-11	NULL
on	NULL
IgG	NULL
immune	NULL
complex-induced	NULL
lung	NULL
NF-KB	NULL
activation	NULL
.	NULL

(	NULL
A	NULL
)	NULL
NF-KB	NULL
activation	NULL
in	NULL
whole	NULL
lung	NULL
tissues	NULL
harvested	NULL
4	NULL
h	NULL
after	NULL
intratracheal	NULL
administration	NULL
of	NULL
PBS	NULL
or	NULL
1.5	NULL
mg	NULL
anti-BSA	NULL
(	NULL
IgG-IC	NULL
)	NULL
followed	NULL
by	NULL
intravenous	NULL
infusion	NULL
of	NULL
10	NULL
mg	NULL
BSA	NULL
.	NULL

IL-11	NULL
was	NULL
administered	NULL
intratracheally	NULL
with	NULL
the	NULL
IgG	NULL
anti-BSA	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Quantitation	NULL
of	NULL
EMSA	NULL
blots	NULL
by	NULL
image	NULL
analysis	NULL
.	NULL

Values	NULL
represent	NULL
mean	NULL
+	NULL
SEM	NULL
,	NULL
with	NULL
n	NULL
=	NULL
4-5	NULL
for	NULL
each	NULL
group	NULL
.	NULL

154	NULL
-	NULL
Journal	NULL
of	NULL
Leukocyte	NULL
Biology	NULL
Volume	NULL
66	NULL
,	NULL
July	NULL
1999	NULL
800	NULL
&	NULL
&	NULL
O	NULL
1	NULL
70	NULL
%	NULL
decrease	NULL
TNFa	NULL
(	NULL
ng/ml	NULL
)	NULL
Io	NULL
&	NULL
anl	NULL
1	NULL
0	NULL
B	NULL
``	NULL
I	NULL
18	NULL
a	NULL
<	NULL
O	NULL
z	NULL
17	NULL
Jam	NULL
g	NULL
48	NULL
%	NULL
decrease	NULL
8	NULL
.S	NULL
p	NULL
<	NULL
0.05	NULL
dp	NULL
8	NULL
2	NULL
>	NULL
Eis	NULL
)	NULL
(	NULL
--	NULL
J	NULL
&	NULL
3	NULL
14	NULL
PBS	NULL
-	NULL
IgG-IC_	NULL
1gG-IC	NULL
+	NULL
IL-11	NULL
Fig	NULL
.	NULL

5	NULL
.	NULL

Effects	NULL
of	NULL
IL-11	NULL
on	NULL
IgG	NULL
immune	NULL
complex-induced	NULL
BAL	NULL
TNF-a	NULL
and	NULL
lung	NULL
vascular	NULL
ICAM-1	NULL
expression	NULL
.	NULL

(	NULL
A	NULL
)	NULL
BAL	NULL
fluids	NULL
harvested	NULL
4	NULL
h	NULL
after	NULL
intratracheal	NULL
administration	NULL
of	NULL
PBS	NULL
or	NULL
1.5	NULL
mg	NULL
anti-BSA	NULL
(	NULL
IgG-IC	NULL
)	NULL
followed	NULL
by	NULL
intravenous	NULL
infusion	NULL
of	NULL
10	NULL
mg	NULL
BSA	NULL
were	NULL
analyzed	NULL
by	NULL
the	NULL
WEHI	NULL
assay	NULL
for	NULL
bioactivity	NULL
.	NULL

(	NULL
B	NULL
)	NULL
lung	NULL
vascular	NULL
ICAM-1	NULL
expression	NULL
was	NULL
determined	NULL
4	NULL
h	NULL
after	NULL
IgG-IC	NULL
deposition	NULL
using	NULL
vascular	NULL
fixation	NULL
of	NULL
*	NULL
``	NULL
T-anti-rat	NULL
ICAM-1	NULL
.	NULL

Values	NULL
represent	NULL
mean	NULL
+	NULL
SEM	NULL
,	NULL
with	NULL
n	NULL
=	NULL
5-6	NULL
for	NULL
each	NULL
group	NULL
.	NULL

30	NULL
,	NULL
or	NULL
60	NULL
pg	NULL
IL-11	NULL
,	NULL
NF-KB	NULL
activation	NULL
was	NULL
reduced	NULL
by	NULL
12	NULL
(	NULL
P	NULL
,	NULL
NS	NULL
)	NULL
,	NULL
28	NULL
(	NULL
P	NULL
,	NULL
NS	NULL
)	NULL
,	NULL
and	NULL
34	NULL
%	NULL
(	NULL
P	NULL
<	NULL
0.05	NULL
)	NULL
,	NULL
respectively	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
)	NULL
.	NULL

Effects	NULL
of	NULL
IL-11	NULL
on	NULL
BAL	NULL
Levels	NULL
of	NULL
TNF-a	NULL
and	NULL
lung	NULL
vascular	NULL
expression	NULL
of	NULL
ICAM-1	NULL
NF-KB	NULL
is	NULL
known	NULL
to	NULL
control	NULL
,	NULL
at	NULL
least	NULL
in	NULL
part	NULL
,	NULL
the	NULL
gene	NULL
expression	NULL
of	NULL
both	NULL
TNF-a	NULL
and	NULL
ICAM-1	NULL
[	NULL
22	NULL
,	NULL
23	NULL
]	NULL
.	NULL

Furthermore	NULL
,	NULL
TNF-a	NULL
regulates	NULL
lung	NULL
vascular	NULL
expression	NULL
of	NULL
ICAM-1	NULL
[	NULL
17	NULL
]	NULL
,	NULL
which	NULL
is	NULL
required	NULL
for	NULL
pulmonary	NULL
neutrophil	NULL
recruitment	NULL
[	NULL
24	NULL
]	NULL
.	NULL

Therefore	NULL
,	NULL
we	NULL
performed	NULL
experiments	NULL
to	NULL
determine	NULL
whether	NULL
exogenously	NULL
administered	NULL
IL-11	NULL
affected	NULL
BAL	NULL
levels	NULL
of	NULL
TNF-	NULL
and	NULL
lung	NULL
vascular	NULL
expression	NULL
of	NULL
ICAM-1	NULL
.	NULL

BAL	NULL
TNF-	NULL
content	NULL
was	NULL
determined	NULL
by	NULL
the	NULL
WEHI	NULL
bioassay	NULL
.	NULL

The	NULL
lung	NULL
inflammatory	NULL
response	NULL
led	NULL
to	NULL
significantly	NULL
increased	NULL
BAL	NULL
levels	NULL
of	NULL
TNF-a	NULL
(	NULL
from	NULL
<	NULL
20	NULL
ng/ml	NULL
to	NULL
>	NULL
600	NULL
ng/mL	NULL
,	NULL
Fig	NULL
.	NULL

5	NULL
A	NULL
)	NULL
.	NULL

In	NULL
the	NULL
presence	NULL
of	NULL
60	NULL
ug	NULL
IL-11	NULL
BAL	NULL
levels	NULL
of	NULL
TNF-a	NULL
were	NULL
reduced	NULL
by	NULL
70	NULL
%	NULL
(	NULL
P	NULL
<	NULL
0.05	NULL
)	NULL
.	NULL

Pulmonary	NULL
expression	NULL
of	NULL
ICAM-1	NULL
was	NULL
determined	NULL
by	NULL
the	NULL
lung	NULL
binding	NULL
index	NULL
of	NULL
**	NULL
``	NULL
I-anti-ICAM-1	NULL
.	NULL

As	NULL
expected	NULL
,	NULL
intrapul-	NULL
http	NULL
:	NULL
//www.jleukbi0.org	NULL
monary	NULL
deposition	NULL
of	NULL
IgG	NULL
immune	NULL
complexes	NULL
caused	NULL
a	NULL
significant	NULL
increase	NULL
in	NULL
the	NULL
ICAM-1	NULL
binding	NULL
index	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
)	NULL
.	NULL

In	NULL
the	NULL
presence	NULL
of	NULL
60	NULL
ug	NULL
IL-11	NULL
,	NULL
the	NULL
binding	NULL
index	NULL
for	NULL
ICAM-1	NULL
was	NULL
reduced	NULL
by	NULL
48	NULL
%	NULL
(	NULL
P	NULL
<	NULL
0.05	NULL
)	NULL
.	NULL

The	NULL
increase	NULL
in	NULL
binding	NULL
index	NULL
for	NULL
the	NULL
anti-ICAM-1	NULL
could	NULL
not	NULL
be	NULL
attributed	NULL
to	NULL
nonspecific	NULL
binding	NULL
or	NULL
sequestration	NULL
due	NULL
to	NULL
lung	NULL
injury	NULL
because	NULL
the	NULL
binding	NULL
index	NULL
for	NULL
the	NULL
irrelevant	NULL
IgG	NULL
control	NULL
antibody	NULL
was	NULL
less	NULL
than	NULL
0.10	NULL
in	NULL
both	NULL
inflamed	NULL
and	NULL
non-inflamed	NULL
lungs	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Effects	NULL
of	NULL
IL-11	NULL
on	NULL
neutrophil	NULL
chemoattractants	NULL
in	NULL
BAL	NULL
fluids	NULL
To	NULL
determine	NULL
the	NULL
effects	NULL
of	NULL
IL-11	NULL
on	NULL
chemotactic	NULL
mediators	NULL
known	NULL
to	NULL
be	NULL
involved	NULL
in	NULL
pulmonary	NULL
neutrophil	NULL
recruitment	NULL
in	NULL
this	NULL
inflammatory	NULL
model	NULL
,	NULL
we	NULL
assessed	NULL
the	NULL
effects	NULL
of	NULL
60	NULL
ug	NULL
IL-11	NULL
on	NULL
IgG	NULL
immune	NULL
complex-induced	NULL
BAL	NULL
content	NULL
of	NULL
the	NULL
CXC	NULL
chemokines	NULL
,	NULL
MIP-2	NULL
and	NULL
CINC	NULL
,	NULL
and	NULL
the	NULL
complement	NULL
activation	NULL
product	NULL
,	NULL
C5a	NULL
.	NULL

BAL	NULL
fluids	NULL
were	NULL
obtained	NULL
4	NULL
h	NULL
after	NULL
the	NULL
initiation	NULL
of	NULL
the	NULL
lung	NULL
inflammatory	NULL
reaction	NULL
.	NULL

MIP-2	NULL
,	NULL
CINC	NULL
,	NULL
and	NULL
C5a	NULL
were	NULL
evaluated	NULL
by	NULL
ELISA	NULL
.	NULL

Intrapulmonary	NULL
deposition	NULL
of	NULL
IgG	NULL
immune	NULL
complexes	NULL
caused	NULL
significant	NULL
increases	NULL
in	NULL
BAL	NULL
levels	NULL
of	NULL
MIP-2	NULL
,	NULL
CINC	NULL
,	NULL
and	NULL
CSa	NULL
,	NULL
with	NULL
a	NULL
38-fold	NULL
increase	NULL
of	NULL
MIP-2	NULL
,	NULL
a	NULL
nearly	NULL
300-fold	NULL
increase	NULL
of	NULL
CINC	NULL
,	NULL
and	NULL
a	NULL
7-fold	NULL
increase	NULL
of	NULL
C5a	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

In	NULL
the	NULL
presence	NULL
of	NULL
60	NULL
ug	NULL
IL-11	NULL
,	NULL
the	NULL
BAL	NULL
levels	NULL
of	NULL
MIP-2	NULL
and	NULL
CINC	NULL
were	NULL
not	NULL
significantly	NULL
altered	NULL
but	NULL
there	NULL
was	NULL
a	NULL
29	NULL
%	NULL
decrease	NULL
(	NULL
P	NULL
<	NULL
0.05	NULL
)	NULL
in	NULL
BAL	NULL
levels	NULL
of	NULL
C5a	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

DISCUSSION	NULL
There	NULL
is	NULL
mounting	NULL
evidence	NULL
that	NULL
IL-11	NULL
plays	NULL
an	NULL
important	NULL
regulatory	NULL
role	NULL
in	NULL
the	NULL
inflammatory	NULL
response	NULL
.	NULL

Previous	NULL
studies	NULL
have	NULL
suggested	NULL
that	NULL
exogenously	NULL
administered	NULL
IL-11	NULL
reduced	NULL
tissue	NULL
injury	NULL
in	NULL
a	NULL
number	NULL
of	NULL
experimental	NULL
models	NULL
of	NULL
chronic	NULL
inflammatory	NULL
disease	NULL
,	NULL
including	NULL
TNBS-induced	NULL
colitis	NULL
,	NULL
endotox-emia	NULL
,	NULL
and	NULL
radiation-induced	NULL
thoracic	NULL
injury	NULL
[	NULL
11-13	NULL
]	NULL
.	NULL

In	NULL
the	NULL
last	NULL
example	NULL
,	NULL
the	NULL
protective	NULL
effects	NULL
of	NULL
IL-11	NULL
correlated	NULL
with	NULL
reduced	NULL
intrapulmonary	NULL
production	NULL
of	NULL
TNF-a	NULL
[	NULL
13	NULL
]	NULL
.	NULL

In	NULL
the	NULL
current	NULL
study	NULL
,	NULL
we	NULL
investigated	NULL
whether	NULL
IL-11	NULL
could	NULL
suppress	NULL
the	NULL
acute	NULL
inflammatory	NULL
response	NULL
in	NULL
lung	NULL
and	NULL
if	NULL
so	NULL
,	NULL
by	NULL
what	NULL
mechanism	NULL
.	NULL

Intrapulmonary	NULL
deposition	NULL
of	NULL
IgG	NULL
immune	NULL
complexes	NULL
causes	NULL
distal	NULL
airway	NULL
activation	NULL
of	NULL
the	NULL
complement	NULL
system	NULL
and	NULL
generation	NULL
of	NULL
the	NULL
complement	NULL
activation	NULL
product	NULL
,	NULL
C5a	NULL
.	NULL

Blockade	NULL
of	NULL
intrapulmonary	NULL
C5a	NULL
with	NULL
antibody	NULL
reduced	NULL
lung	NULL
production	NULL
of	NULL
TNF-a	NULL
,	NULL
diminished	NULL
up-regulation	NULL
of	NULL
vascular	NULL
ICAM-1	NULL
,	NULL
and	NULL
reduced	NULL
neutrophil	NULL
accumulation	NULL
and	NULL
the	NULL
intensity	NULL
of	NULL
lung	NULL
injury	NULL
[	NULL
25	NULL
]	NULL
.	NULL

In	NULL
this	NULL
lung	NULL
inflammatory	NULL
model	NULL
,	NULL
enhanced	NULL
production	NULL
of	NULL
TNF-a	NULL
and	NULL
IL-1	NULL
by	NULL
activated	NULL
macrophages	NULL
is	NULL
required	NULL
TABLE	NULL
1	NULL
.	NULL

Effects	NULL
of	NULL
IL-11	NULL
on	NULL
BAL	NULL
Levels	NULL
of	NULL
MIP-2	NULL
,	NULL
CINC	NULL
,	NULL
and	NULL
C5a	NULL
Group	NULL
MIP-2	NULL
(	NULL
ng/mL	NULL
)	NULL
CINC	NULL
(	NULL
ng/mL	NULL
)	NULL
Ca	NULL
(	NULL
ng/mL	NULL
)	NULL
PBS	NULL
15.1	NULL
+	NULL
8.6	NULL
5.6	NULL
+	NULL
6.3	NULL
0.35	NULL
+	NULL
0.05	NULL
IgG-1C	NULL
572.6	NULL
+	NULL
68.9*	NULL
1589.8	NULL
+	NULL
1837.9*	NULL
2.42	NULL
+	NULL
0.183*	NULL
IgG-IC	NULL
+	NULL
IL-11	NULL
-	NULL
508.6	NULL
+	NULL
31.7*	NULL
1478.6	NULL
+	NULL
78.7*	NULL
1.82	NULL
+	NULL
0.14f	NULL
Values	NULL
represent	NULL
mean	NULL
+L	NULL
SEM	NULL
,	NULL
with	NULL
n	NULL
=	NULL
5	NULL
for	NULL
each	NULL
group	NULL
.	NULL

Human	NULL
recombinant	NULL
IL-11	NULL
was	NULL
used	NULL
at	NULL
a	NULL
dose	NULL
of	NULL
60	NULL
ug	NULL
,	NULL
administered	NULL
intratracheally	NULL
.	NULL

IC	NULL
,	NULL
immune	NULL
complexes	NULL
.	NULL

*	NULL
P	NULL
<	NULL
0.05	NULL
compared	NULL
to	NULL
PBS	NULL
group	NULL
;	NULL
t	NULL
P	NULL
<	NULL
0.05	NULL
compared	NULL
to	NULL
IgG-IC	NULL
group	NULL
.	NULL

for	NULL
up-regulation	NULL
of	NULL
the	NULL
adhesion	NULL
molecules	NULL
,	NULL
ICAM-1	NULL
and	NULL
E-selectin	NULL
,	NULL
on	NULL
pulmonary	NULL
vascular	NULL
endothelial	NULL
cells	NULL
[	NULL
17	NULL
,	NULL
26	NULL
]	NULL
.	NULL

Interactions	NULL
of	NULL
these	NULL
vascular	NULL
adhesion	NULL
molecules	NULL
with	NULL
their	NULL
respective	NULL
ligands	NULL
on	NULL
blood	NULL
neutrophils	NULL
causes	NULL
leukocyte	NULL
adhesion	NULL
to	NULL
the	NULL
endothelium	NULL
and	NULL
CXC	NULL
chemokine-dependent	NULL
recruitment	NULL
of	NULL
neutrophils	NULL
into	NULL
the	NULL
alveolar	NULL
compartment	NULL
.	NULL

The	NULL
ensuing	NULL
lung	NULL
injury	NULL
is	NULL
mediated	NULL
by	NULL
oxidants	NULL
and	NULL
proteases	NULL
released	NULL
by	NULL
neutrophils	NULL
and	NULL
from	NULL
activated	NULL
lung	NULL
macrophages	NULL
.	NULL

Injury	NULL
is	NULL
characterized	NULL
by	NULL
increased	NULL
vascular	NULL
permeability	NULL
and	NULL
alveolar	NULL
hemorrhage	NULL
[	NULL
27	NULL
]	NULL
.	NULL

In	NULL
this	NULL
study	NULL
we	NULL
found	NULL
that	NULL
IL-11	NULL
was	NULL
up-regulated	NULL
at	NULL
the	NULL
mRNA	NULL
and	NULL
protein	NULL
levels	NULL
during	NULL
the	NULL
lung	NULL
inflammatory	NULL
response	NULL
.	NULL

Exogenously	NULL
administered	NULL
IL-11	NULL
attenuated	NULL
intrapulmonary	NULL
activation	NULL
of	NULL
NF-KB	NULL
,	NULL
reduced	NULL
lung	NULL
production	NULL
of	NULL
TNF-a	NULL
@	NULL
,	NULL
and	NULL
diminished	NULL
pulmonary	NULL
vascular	NULL
expression	NULL
of	NULL
ICAM-1	NULL
.	NULL

In	NULL
the	NULL
presence	NULL
of	NULL
IL-11	NULL
,	NULL
intrapulmonary	NULL
generation	NULL
of	NULL
C5a	NULL
was	NULL
reduced	NULL
by	NULL
an	NULL
unknown	NULL
mechanism	NULL
.	NULL

These	NULL
effects	NULL
were	NULL
accompanied	NULL
by	NULL
reduced	NULL
neutrophil	NULL
accumulation	NULL
and	NULL
lung	NULL
injury	NULL
.	NULL

The	NULL
data	NULL
suggest	NULL
that	NULL
IL-11	NULL
may	NULL
function	NULL
as	NULL
an	NULL
intrinsic	NULL
regulator	NULL
of	NULL
the	NULL
acute	NULL
inflammatory	NULL
response	NULL
in	NULL
lung	NULL
.	NULL

The	NULL
lack	NULL
of	NULL
availability	NULL
of	NULL
a	NULL
blocking	NULL
antibody	NULL
to	NULL
rat	NULL
IL-11	NULL
precludes	NULL
the	NULL
definitive	NULL
in	NULL
vivo	NULL
experiments	NULL
to	NULL
settle	NULL
this	NULL
question	NULL
.	NULL

Exogenous	NULL
administration	NULL
of	NULL
IL-11	NULL
attenuated	NULL
activation	NULL
of	NULL
NF-KB	NULL
in	NULL
lung	NULL
.	NULL

These	NULL
findings	NULL
are	NULL
consistent	NULL
with	NULL
in	NULL
vitro	NULL
studies	NULL
which	NULL
showed	NULL
that	NULL
IL-11	NULL
inhibited	NULL
LPS-induced	NULL
NF-KB	NULL
activation	NULL
in	NULL
macrophages	NULL
[	NULL
10	NULL
]	NULL
.	NULL

It	NULL
is	NULL
interesting	NULL
that	NULL
IL-11	NULL
reduced	NULL
IgG	NULL
immune	NULL
complex-induced	NULL
lung	NULL
NF-KB	NULL
activation	NULL
by	NULL
34	NULL
%	NULL
,	NULL
whereas	NULL
TNF-o	NULL
production	NULL
was	NULL
reduced	NULL
by	NULL
70	NULL
%	NULL
.	NULL

Previous	NULL
studies	NULL
in	NULL
this	NULL
model	NULL
have	NULL
demonstrated	NULL
that	NULL
exogenous	NULL
administration	NULL
of	NULL
the	NULL
anti-inflammatory	NULL
cytokines	NULL
,	NULL
IL-10	NULL
and	NULL
IL-13	NULL
,	NULL
almost	NULL
completely	NULL
inhibits	NULL
lung	NULL
NF-KB	NULL
activation	NULL
and	NULL
suppresses	NULL
TNF-	NULL
«	NULL
@	NULL
production	NULL
by	NULL
more	NULL
than	NULL
95	NULL
%	NULL
[	NULL
9	NULL
,	NULL
281	NULL
.	NULL

Despite	NULL
the	NULL
fact	NULL
that	NULL
IL-10	NULL
and	NULL
IL-13	NULL
signal	NULL
through	NULL
receptor	NULL
pathways	NULL
different	NULL
from	NULL
the	NULL
pathway	NULL
for	NULL
IL-11	NULL
,	NULL
it	NULL
would	NULL
seem	NULL
that	NULL
the	NULL
reduction	NULL
in	NULL
lung	NULL
NF-KB	NULL
activation	NULL
caused	NULL
by	NULL
IL-11	NULL
may	NULL
only	NULL
partially	NULL
explain	NULL
inhibition	NULL
of	NULL
TNF-a	NULL
in	NULL
BAL	NULL
fluids	NULL
.	NULL

If	NULL
it	NULL
is	NULL
predominantly	NULL
macrophages	NULL
that	NULL
are	NULL
the	NULL
target	NULL
for	NULL
the	NULL
suppressive	NULL
effects	NULL
of	NULL
IL-11	NULL
,	NULL
nuclear	NULL
extracts	NULL
from	NULL
whole	NULL
lungs	NULL
may	NULL
underestimate	NULL
the	NULL
suppression	NULL
of	NULL
NF-KB	NULL
in	NULL
lung	NULL
macrophages	NULL
.	NULL

In	NULL
the	NULL
lung	NULL
inflammatory	NULL
response	NULL
,	NULL
intrapulmonary	NULL
generation	NULL
of	NULL
C5a	NULL
is	NULL
known	NULL
to	NULL
be	NULL
required	NULL
for	NULL
the	NULL
full	NULL
production	NULL
of	NULL
TNF-a	NULL
[	NULL
25	NULL
]	NULL
.	NULL

The	NULL
present	NULL
report	NULL
provides	NULL
evidence	NULL
that	NULL
IL-11	NULL
reduces	NULL
the	NULL
generation	NULL
of	NULL
C5a	NULL
during	NULL
IgG	NULL
immune	NULL
complex	NULL
alveolitis	NULL
.	NULL

How	NULL
IL-11	NULL
might	NULL
affect	NULL
the	NULL
intrapulmonary	NULL
generation	NULL
of	NULL
C5a	NULL
is	NULL
unclear	NULL
IL-11	NULL
is	NULL
known	NULL
to	NULL
stimulate	NULL
the	NULL
production	NULL
of	NULL
the	NULL
tissue	NULL
inhibitor	NULL
of	NULL
metalloproteinase-1	NULL
[	NULL
29	NULL
]	NULL
.	NULL

If	NULL
a	NULL
non-complement-related	NULL
C5-cleaving	NULL
enzyme	NULL
in	NULL
lung	NULL
,	NULL
such	NULL
as	NULL
a	NULL
matrix	NULL
metalloproteinase	NULL
,	NULL
is	NULL
responsible	NULL
for	NULL
production	NULL
of	NULL
at	NULL
least	NULL
some	NULL
C5a	NULL
,	NULL
it	NULL
is	NULL
possible	NULL
that	NULL
IL-11	NULL
induces	NULL
up-regulation	NULL
of	NULL
natural	NULL
inhibitors	NULL
for	NULL
such	NULL
an	NULL
enzyme	NULL
(	NULL
e.g	NULL
.	NULL

,	NULL
by	NULL
up-regulating	NULL
tissue	NULL
inhibitor	NULL
of	NULL
metalloproteinase-2	NULL
)	NULL
,	NULL
thereby	NULL
reducing	NULL
the	NULL
amount	NULL
of	NULL
C5a	NULL
generated	NULL
.	NULL

Until	NULL
the	NULL
nature	NULL
of	NULL
the	NULL
C5-cleaving	NULL
enzyme	NULL
in	NULL
lung	NULL
is	NULL
known	NULL
,	NULL
the	NULL
possible	NULL
mechanism	NULL
of	NULL
the	NULL
suppressive	NULL
effects	NULL
of	NULL
IL-11	NULL
on	NULL
C§a	NULL
generation	NULL
remains	NULL
specu-lative	NULL
.	NULL

Accordingly	NULL
,	NULL
the	NULL
effects	NULL
of	NULL
IL-11	NULL
in	NULL
vivo	NULL
suggest	NULL
that	NULL
IL-11	NULL
may	NULL
reduce	NULL
lung	NULL
production	NULL
of	NULL
TNF-a	NULL
by	NULL
two	NULL
separate	NULL
mechanisms	NULL
involving	NULL
NF-KB	NULL
and	NULL
C5a	NULL
.	NULL

These	NULL
mechanisms	NULL
may	NULL
Lentsch	NULL
et	NULL
al	NULL
.	NULL

-	NULL
Regulatory	NULL
effects	NULL
of	NULL
IL-11	NULL
155	NULL
also	NULL
be	NULL
relevant	NULL
to	NULL
the	NULL
regulation	NULL
of	NULL
pulmonary	NULL
vascular	NULL
expression	NULL
of	NULL
ICAM-1	NULL
.	NULL

Both	NULL
NF-KB	NULL
and	NULL
C5a	NULL
are	NULL
known	NULL
to	NULL
regulate	NULL
,	NULL
by	NULL
direct	NULL
or	NULL
indirect	NULL
mechanisms	NULL
,	NULL
vascular	NULL
endothelial	NULL
cell	NULL
expression	NULL
of	NULL
ICAM-1	NULL
.	NULL

NF-KB	NULL
directly	NULL
controls	NULL
gene	NULL
expression	NULL
of	NULL
ICAM-1	NULL
as	NULL
well	NULL
as	NULL
the	NULL
ICAM-1	NULL
inducer	NULL
,	NULL
TNF-a	NULL
[	NULL
22	NULL
,	NULL
23	NULL
]	NULL
,	NULL
whereas	NULL
C5a	NULL
regulates	NULL
ICAM-1	NULL
expression	NULL
through	NULL
effects	NULL
on	NULL
TNF-a	NULL
production	NULL
[	NULL
25	NULL
]	NULL
.	NULL

It	NULL
seems	NULL
likely	NULL
that	NULL
IL-11-induced	NULL
inhibition	NULL
of	NULL
pulmonary	NULL
neutrophil	NULL
recruitment	NULL
and	NULL
ensuing	NULL
lung	NULL
injury	NULL
can	NULL
be	NULL
attributed	NULL
to	NULL
reductions	NULL
in	NULL
intrapulmonary	NULL
C5a	NULL
,	NULL
TNF-	NULL
@	NULL
,	NULL
and	NULL
pulmonary	NULL
vascular	NULL
expression	NULL
of	NULL
ICAM-1	NULL
because	NULL
IL-11	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
the	NULL
CXC	NULL
chemokines	NULL
,	NULL
MIP-2	NULL
and	NULL
CINC	NULL
.	NULL

As	NULL
indicated	NULL
above	NULL
,	NULL
both	NULL
of	NULL
these	NULL
CXC	NULL
chemokines	NULL
are	NULL
known	NULL
to	NULL
be	NULL
required	NULL
for	NULL
full	NULL
recruitment	NULL
of	NULL
neutrophils	NULL
in	NULL
this	NULL
model	NULL
of	NULL
lung	NULL
injury	NULL
.	NULL

It	NULL
remains	NULL
to	NULL
be	NULL
determined	NULL
how	NULL
the	NULL
presence	NULL
of	NULL
IL-11	NULL
affects	NULL
intrapulmonary	NULL
generation	NULL
of	NULL
C5a	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
regulatory	NULL
effects	NULL
of	NULL
IL-11	NULL
on	NULL
the	NULL
lung	NULL
inflammatory	NULL
response	NULL
are	NULL
restricted	NULL
in	NULL
scope	NULL
.	NULL

Why	NULL
transgenic	NULL
expression	NULL
of	NULL
IL-11	NULL
in	NULL
murine	NULL
lung	NULL
leads	NULL
to	NULL
accumulation	NULL
of	NULL
lymphocytes	NULL
and	NULL
increased	NULL
airway	NULL
resistance	NULL
is	NULL
not	NULL
clear	NULL
[	NULL
14	NULL
]	NULL
.	NULL

However	NULL
,	NULL
the	NULL
predominantly	NULL
B	NULL
cell	NULL
phenotype	NULL
of	NULL
the	NULL
lung	NULL
lymphocytic	NULL
infiltrates	NULL
in	NULL
IL-11	NULL
transgenic	NULL
mice	NULL
suggests	NULL
that	NULL
the	NULL
B	NULL
cell	NULL
stimulatory	NULL
activity	NULL
of	NULL
IL-11	NULL
may	NULL
contribute	NULL
to	NULL
this	NULL
outcome	NULL
[	NULL
30	NULL
]	NULL
.	NULL

The	NULL
mechanisms	NULL
for	NULL
the	NULL
fibrotic	NULL
airway	NULL
obstruction	NULL
in	NULL
IL-11	NULL
transgenic	NULL
mice	NULL
remains	NULL
to	NULL
be	NULL
determined	NULL
.	NULL

Whether	NULL
intermittent	NULL
expression	NULL
of	NULL
IL-11	NULL
in	NULL
lung	NULL
would	NULL
yield	NULL
an	NULL
outcome	NULL
different	NULL
from	NULL
persistent	NULL
expression	NULL
of	NULL
IL-11	NULL
in	NULL
transgenic	NULL
mice	NULL
is	NULL
unclear	NULL
.	NULL

This	NULL
report	NULL
further	NULL
extends	NULL
our	NULL
current	NULL
knowledge	NULL
concerning	NULL
the	NULL
biology	NULL
of	NULL
IL-11	NULL
.	NULL

We	NULL
demonstrate	NULL
the	NULL
anti-inflammatory	NULL
effects	NULL
of	NULL
IL-11	NULL
and	NULL
have	NULL
identified	NULL
the	NULL
protective	NULL
mechanisms	NULL
of	NULL
IL-11	NULL
in	NULL
lung	NULL
after	NULL
intrapulmonary	NULL
deposition	NULL
of	NULL
IgG	NULL
immune	NULL
complexes	NULL
.	NULL

The	NULL
data	NULL
demonstrate	NULL
that	NULL
IL-11	NULL
functions	NULL
as	NULL
a	NULL
down-regulator	NULL
of	NULL
the	NULL
acute	NULL
inflammatory	NULL
response	NULL
.	NULL

Further	NULL
more	NULL
,	NULL
IL-11	NULL
is	NULL
up-regulated	NULL
at	NULL
the	NULL
mRNA	NULL
and	NULL
protein	NULL
levels	NULL
during	NULL
the	NULL
course	NULL
of	NULL
inflammation	NULL
.	NULL

These	NULL
findings	NULL
are	NULL
similar	NULL
to	NULL
those	NULL
described	NULL
previously	NULL
for	NULL
IL-6	NULL
,	NULL
suggesting	NULL
that	NULL
IL-11	NULL
may	NULL
have	NULL
overlapping	NULL
functions	NULL
with	NULL
IL-6	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
acute	NULL
lung	NULL
inflammation	NULL
.	NULL

The	NULL
dose	NULL
responses	NULL
of	NULL
IL-6	NULL
and	NULL
IL-11	NULL
are	NULL
similar	NULL
and	NULL
are	NULL
a	NULL
log	NULL
dose	NULL
greater	NULL
than	NULL
for	NULL
the	NULL
effects	NULL
of	NULL
IL-10	NULL
and	NULL
IL-13	NULL
[	NULL
28	NULL
]	NULL
.	NULL

All	NULL
of	NULL
these	NULL
interleukins	NULL
appear	NULL
to	NULL
achieve	NULL
these	NULL
effects	NULL
via	NULL
a	NULL
common	NULL
mechanism	NULL
:	NULL
suppression	NULL
of	NULL
NF-KB	NULL
activation	NULL
and	NULL
related	NULL
TNF-a	NULL
production	NULL
in	NULL
lung	NULL
,	NULL
leading	NULL
to	NULL
reduced	NULL
expression	NULL
of	NULL
lung	NULL
vascular	NULL
ICAM-1	NULL
.	NULL

In	NULL
turn	NULL
,	NULL
neutrophil	NULL
recruitment	NULL
is	NULL
reduced	NULL
,	NULL
as	NULL
is	NULL
the	NULL
development	NULL
of	NULL
lung	NULL
injury	NULL
.	NULL

At	NULL
present	NULL
,	NULL
IL-11	NULL
can	NULL
be	NULL
added	NULL
to	NULL
the	NULL
list	NULL
of	NULL
regulatory	NULL
cytokines	NULL
,	NULL
which	NULL
also	NULL
include	NULL
IL-4	NULL
,	NULL
IL-6	NULL
,	NULL
IL-10	NULL
,	NULL
IL-12	NULL
,	NULL
and	NULL
IL-13	NULL
.	NULL

ACKNOWLEDGMENTS	NULL
This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
Grants	NULL
HL-31963	NULL
,	NULL
HL-07517	NULL
,	NULL
and	NULL
GM-29507	NULL
.	NULL

The	NULL
recombinant	NULL
human	NULL
IL-11	NULL
and	NULL
monoclonal	NULL
mouse	NULL
IgG	NULL
anti-IL-11	NULL
were	NULL
gifts	NULL
from	NULL
Genetics	NULL
Institute	NULL
,	NULL
Cambridge	NULL
,	NULL
MA	NULL
.	NULL

156	NULL
-	NULL
Journal	NULL
of	NULL
Leukocyte	NULL
Biology	NULL
Volume	NULL
66	NULL
,	NULL
July	NULL
1999	NULL
REFERENCES	NULL
1	NULL
.	NULL

Paul	NULL
,	NULL
S.	NULL
R.	NULL
,	NULL
Bennett	NULL
,	NULL
F.	NULL
,	NULL
Calvetti	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
Kelleher	NULL
,	NULL
K.	NULL
,	NULL
Wood	NULL
,	NULL
C.	NULL
R.	NULL
,	NULL
O'Hara	NULL
,	NULL
R.	NULL
M.	NULL
,	NULL
Leary	NULL
,	NULL
A.	NULL
C.	NULL
,	NULL
Sibley	NULL
,	NULL
B.	NULL
,	NULL
Clark	NULL
,	NULL
S.	NULL
C.	NULL
,	NULL
Williams	NULL
,	NULL
D.	NULL
A.	NULL
Yang	NULL
,	NULL
Y.	NULL
C.	NULL
(	NULL
1990	NULL
)	NULL
Molecular	NULL
cloning	NULL
of	NULL
a	NULL
cDNA	NULL
encoding	NULL
interleukin	NULL
11	NULL
,	NULL
a	NULL
stromal	NULL
cell-derived	NULL
lymphopoietic	NULL
and	NULL
hematopoietic	NULL
cytokine	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
87	NULL
,	NULL
7512-7516	NULL
.	NULL

2	NULL
.	NULL

Weich	NULL
,	NULL
N.	NULL
S.	NULL
,	NULL
Wang	NULL
,	NULL
A.	NULL
,	NULL
Fitzgerald	NULL
,	NULL
M.	NULL
,	NULL
Neben	NULL
,	NULL
T.	NULL
Y.	NULL
,	NULL
Donaldson	NULL
,	NULL
D.	NULL
,	NULL
Giannotti	NULL
,	NULL
J.	NULL
,	NULL
Yetz-Aldape	NULL
,	NULL
J.	NULL
,	NULL
Leven	NULL
,	NULL
R.	NULL
M.	NULL
,	NULL
Turner	NULL
K.	NULL
J	NULL
.	NULL

(	NULL
1997	NULL
)	NULL
Recombinant	NULL
human	NULL
interleukin-11	NULL
directly	NULL
promotes	NULL
megakaryocytopoi-esis	NULL
in	NULL
vitro	NULL
.	NULL

Blood	NULL
90	NULL
,	NULL
3893-3902	NULL
.	NULL

3	NULL
.	NULL

Baumann	NULL
,	NULL
H.	NULL
,	NULL
Schendel	NULL
,	NULL
P.	NULL
(	NULL
1991	NULL
)	NULL
Interleukin-11	NULL
regulates	NULL
the	NULL
hepatic	NULL
expression	NULL
of	NULL
the	NULL
same	NULL
plasma	NULL
protein	NULL
genes	NULL
as	NULL
interleukin-6	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

266	NULL
,	NULL
20424-20427	NULL
.	NULL

4	NULL
.	NULL

Yin	NULL
,	NULL
T.	NULL
,	NULL
Taga	NULL
,	NULL
T.	NULL
,	NULL
Tsang	NULL
,	NULL
M.	NULL
L.	NULL
,	NULL
Yasukawa	NULL
,	NULL
K.	NULL
,	NULL
Kishimoto	NULL
,	NULL
T.	NULL
,	NULL
Yang	NULL
,	NULL
Y.	NULL
C.	NULL
(	NULL
1993	NULL
)	NULL
Involvement	NULL
of	NULL
IL-6	NULL
signal	NULL
transducer	NULL
gp130	NULL
in	NULL
IL-11-mediated	NULL
signal	NULL
transduction	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

151	NULL
,	NULL
2555-2561	NULL
.	NULL

5	NULL
.	NULL

Nandurkar	NULL
,	NULL
H.	NULL
H.	NULL
,	NULL
Hilton	NULL
,	NULL
D.	NULL
J.	NULL
,	NULL
Nathan	NULL
,	NULL
P.	NULL
,	NULL
Willson	NULL
,	NULL
T.	NULL
,	NULL
Nicola	NULL
,	NULL
N.	NULL
,	NULL
Begley	NULL
,	NULL
C.	NULL
G.	NULL
(	NULL
1996	NULL
)	NULL
The	NULL
human	NULL
IL-11	NULL
receptor	NULL
requires	NULL
gp130	NULL
for	NULL
signalling	NULL
:	NULL
demonstration	NULL
by	NULL
molecular	NULL
cloning	NULL
of	NULL
the	NULL
receptor	NULL
Oncogene	NULL
12	NULL
,	NULL
585-593	NULL
.	NULL

6	NULL
.	NULL

Shanley	NULL
,	NULL
T.	NULL
P	NULL
,	NULL
Foreback	NULL
,	NULL
J.	NULL
L.	NULL
,	NULL
Remick	NULL
,	NULL
D.	NULL
G.	NULL
,	NULL
Ulich	NULL
,	NULL
T.	NULL
R.	NULL
,	NULL
Kunkel	NULL
,	NULL
S.	NULL
L.	NULL
,	NULL
Ward	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

(	NULL
1997	NULL
)	NULL
Regulatory	NULL
effects	NULL
of	NULL
IL-6	NULL
in	NULL
IgG	NULL
immune	NULL
complex-induced	NULL
lung	NULL
injury	NULL
.	NULL

Am	NULL
.	NULL

J.	NULL
Pathol	NULL
.	NULL

151	NULL
,	NULL
198-203	NULL
.	NULL

7	NULL
.	NULL

Warren	NULL
,	NULL
J.	NULL
S.	NULL
,	NULL
Yabroff	NULL
,	NULL
K.	NULL
R.	NULL
,	NULL
Remick	NULL
,	NULL
D.	NULL
G.	NULL
,	NULL
Kunkel	NULL
,	NULL
S.	NULL
L.	NULL
,	NULL
Chensue	NULL
,	NULL
S.	NULL
W.	NULL
,	NULL
Kunkel	NULL
,	NULL
R.	NULL
G.	NULL
,	NULL
Johnson	NULL
,	NULL
K.	NULL
J.	NULL
,	NULL
Ward	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Tumor	NULL
necrosis	NULL
factor	NULL
participates	NULL
in	NULL
the	NULL
pathogenesis	NULL
of	NULL
acute	NULL
immune	NULL
complex	NULL
alveolitis	NULL
in	NULL
the	NULL
rat	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

84	NULL
,	NULL
1873-1882	NULL
.	NULL

8	NULL
.	NULL

Warren	NULL
,	NULL
J.	NULL
S.	NULL
(	NULL
1991	NULL
)	NULL
Intrapulmonary	NULL
interleukin	NULL
1	NULL
mediates	NULL
acute	NULL
immune	NULL
complex	NULL
alveolitis	NULL
in	NULL
the	NULL
rat	NULL
.	NULL

Biochem	NULL
.	NULL

Biophys	NULL
.	NULL

Res	NULL
.	NULL

Commun	NULL
.	NULL

175	NULL
,	NULL
604-610	NULL
.	NULL

9	NULL
.	NULL

Lentsch	NULL
,	NULL
A	NULL
.	NULL

B.	NULL
,	NULL
Shanley	NULL
,	NULL
T.	NULL
P.	NULL
,	NULL
Sarma	NULL
,	NULL
V.	NULL
,	NULL
Ward	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

(	NULL
1997	NULL
)	NULL
In	NULL
vivo	NULL
suppression	NULL
of	NULL
NF-kB	NULL
and	NULL
preservation	NULL
of	NULL
IKBa	NULL
by	NULL
interleukin-10	NULL
and	NULL
interleukin-13	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

100	NULL
,	NULL
2448-2448	NULL
.	NULL

10	NULL
.	NULL

Trepicchio	NULL
,	NULL
W.	NULL
L.	NULL
,	NULL
Wang	NULL
,	NULL
L.	NULL
,	NULL
Bozza	NULL
,	NULL
M.	NULL
,	NULL
Dorner	NULL
,	NULL
A.	NULL
J	NULL
.	NULL

(	NULL
1997	NULL
)	NULL
IL-11	NULL
regulates	NULL
macrophage	NULL
effector	NULL
function	NULL
through	NULL
the	NULL
inhibition	NULL
of	NULL
nuclear	NULL
factor	NULL
kappaB	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

159	NULL
,	NULL
5661-5670	NULL
.	NULL

11	NULL
.	NULL

Qiu	NULL
,	NULL
B.	NULL
S.	NULL
,	NULL
Pfeiffer	NULL
,	NULL
C.	NULL
J.	NULL
,	NULL
Keith	NULL
,	NULL
J.	NULL
C.	NULL
,	NULL
Jr.	NULL
(	NULL
1996	NULL
)	NULL
Protection	NULL
by	NULL
recombinant	NULL
human	NULL
interleukin-11	NULL
against	NULL
experimental	NULL
TNB-induced	NULL
colitis	NULL
in	NULL
rats	NULL
.	NULL

Dig	NULL
.	NULL

Dis	NULL
.	NULL

Sci	NULL
.	NULL

41	NULL
,	NULL
1625-1630	NULL
.	NULL

12	NULL
.	NULL

Trepicchio	NULL
,	NULL
W.	NULL
L.	NULL
,	NULL
Bozza	NULL
,	NULL
M.	NULL
,	NULL
Pedneault	NULL
,	NULL
G.	NULL
,	NULL
Dorner	NULL
,	NULL
A.	NULL
J	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
Recombinant	NULL
human	NULL
IL-11	NULL
attenuates	NULL
the	NULL
inflammatory	NULL
response	NULL
through	NULL
down-regulation	NULL
of	NULL
proinflammatory	NULL
cytokine	NULL
release	NULL
and	NULL
nitric	NULL
oxide	NULL
production	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

157	NULL
,	NULL
3627-3634	NULL
.	NULL

13	NULL
.	NULL

Redlich	NULL
,	NULL
C.	NULL
A.	NULL
,	NULL
Gao	NULL
,	NULL
X.	NULL
,	NULL
Rockwell	NULL
,	NULL
S.	NULL
,	NULL
Kelley	NULL
,	NULL
M.	NULL
,	NULL
Elias	NULL
,	NULL
J	NULL
.	NULL

A	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
IL-11	NULL
enhances	NULL
survival	NULL
and	NULL
decreases	NULL
TNF	NULL
production	NULL
after	NULL
radiation-induced	NULL
thoraci¢	NULL
injury	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

157	NULL
,	NULL
1705-1710	NULL
.	NULL

14	NULL
.	NULL

Tang	NULL
,	NULL
W.	NULL
,	NULL
Geba	NULL
,	NULL
G.	NULL
P	NULL
,	NULL
Zheng	NULL
,	NULL
T.	NULL
,	NULL
Ray	NULL
,	NULL
P	NULL
,	NULL
Homer	NULL
,	NULL
R.	NULL
J.	NULL
,	NULL
Kuhn	NULL
,	NULL
C.	NULL
,	NULL
II	NULL
,	NULL
Flavell	NULL
,	NULL
R.	NULL
A.	NULL
,	NULL
Elias	NULL
,	NULL
J	NULL
.	NULL

A	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
Targeted	NULL
expression	NULL
of	NULL
IL-11	NULL
in	NULL
the	NULL
murine	NULL
airway	NULL
causes	NULL
lymphocytic	NULL
inflammation	NULL
,	NULL
bronchial	NULL
remodeling	NULL
,	NULL
and	NULL
airways	NULL
obstruction	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

98	NULL
,	NULL
2845-2853	NULL
.	NULL

15	NULL
.	NULL

Chomezynski	NULL
,	NULL
P.	NULL
,	NULL
Sacchi	NULL
,	NULL
N.	NULL
(	NULL
1987	NULL
)	NULL
Single-step	NULL
method	NULL
of	NULL
RNA	NULL
isolation	NULL
by	NULL
acid	NULL
guanidinium	NULL
thiocyanate-phenol-chloroform	NULL
extraction	NULL
.	NULL

Anal	NULL
.	NULL

Biochem	NULL
.	NULL

162	NULL
,	NULL
156-159	NULL
.	NULL

16	NULL
.	NULL

Deryckere	NULL
,	NULL
F.	NULL
,	NULL
Gannon	NULL
,	NULL
F.	NULL
(	NULL
1994	NULL
)	NULL
A	NULL
one-hour	NULL
minipreparation	NULL
technique	NULL
for	NULL
extraction	NULL
of	NULL
DNA-binding	NULL
proteins	NULL
from	NULL
animal	NULL
tissues	NULL
.	NULL

Biotechniques	NULL
16	NULL
,	NULL
405	NULL
.	NULL

17	NULL
.	NULL

Mulligan	NULL
,	NULL
M.	NULL
S.	NULL
,	NULL
Vaporciyan	NULL
,	NULL
A	NULL
.	NULL

A.	NULL
,	NULL
Miyasaka	NULL
,	NULL
M.	NULL
,	NULL
Tamatani	NULL
,	NULL
T.	NULL
,	NULL
Ward	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Tumor	NULL
necrosis	NULL
factor	NULL
alpha	NULL
regulates	NULL
in	NULL
vivo	NULL
intrapulmonary	NULL
expression	NULL
of	NULL
ICAM-1	NULL
.	NULL

Am	NULL
.	NULL

J.	NULL
Pathol	NULL
.	NULL

142	NULL
,	NULL
1739-1749	NULL
.	NULL

18	NULL
.	NULL

Suzuki	NULL
,	NULL
K.	NULL
,	NULL
Ota	NULL
,	NULL
H.	NULL
,	NULL
Sasagawa	NULL
,	NULL
S.	NULL
,	NULL
Sakatani	NULL
,	NULL
T.	NULL
,	NULL
Fujikura	NULL
,	NULL
T.	NULL
(	NULL
1983	NULL
)	NULL
Assay	NULL
method	NULL
for	NULL
myeloperoxidase	NULL
in	NULL
human	NULL
polymorphonuclear	NULL
leukocytes	NULL
.	NULL

Anal	NULL
.	NULL

Biochem	NULL
.	NULL

182	NULL
,	NULL
345-852	NULL
.	NULL

19	NULL
.	NULL

Espevik	NULL
,	NULL
T.	NULL
,	NULL
Nissen-Meyer	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1986	NULL
)	NULL
A	NULL
highly	NULL
sensitive	NULL
cell	NULL
line	NULL
,	NULL
WEHI	NULL
164	NULL
clone	NULL
13	NULL
,	NULL
for	NULL
measuring	NULL
cytotoxic	NULL
factor/tumor	NULL
necrosis	NULL
factor	NULL
from	NULL
human	NULL
monocytes	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

Meth	NULL
.	NULL

95	NULL
,	NULL
99-105	NULL
.	NULL

20	NULL
.	NULL

Shanley	NULL
,	NULL
T.	NULL
P.	NULL
,	NULL
Schmal	NULL
,	NULL
H.	NULL
,	NULL
Warner	NULL
,	NULL
R.	NULL
L.	NULL
,	NULL
Schmid	NULL
,	NULL
E.	NULL
,	NULL
Friedl	NULL
,	NULL
H.	NULL
P.	NULL
,	NULL
Ward	NULL
,	NULL
F.	NULL
A	NULL
.	NULL

(	NULL
1997	NULL
)	NULL
Requirement	NULL
for	NULL
C-X-C	NULL
chemokines	NULL
(	NULL
macrophage	NULL
inflammatory	NULL
protein-2	NULL
and	NULL
cytokine-induced	NULL
neutrophil	NULL
chemoattractant	NULL
)	NULL
in	NULL
IgG	NULL
immune	NULL
complex-induced	NULL
lung	NULL
injury	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

158	NULL
,	NULL
3489-3448	NULL
.	NULL

21	NULL
.	NULL

Schmid	NULL
,	NULL
E.	NULL
,	NULL
Piccolo	NULL
,	NULL
M.	NULL
T.	NULL
,	NULL
Friedl	NULL
,	NULL
H.	NULL
P.	NULL
,	NULL
Warner	NULL
,	NULL
R.	NULL
L.	NULL
,	NULL
Mulligan	NULL
,	NULL
M.	NULL
S.	NULL
,	NULL
Hugli	NULL
,	NULL
T.	NULL
E.	NULL
,	NULL
Till	NULL
,	NULL
G.	NULL
O.	NULL
,	NULL
Ward	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

(	NULL
1997	NULL
)	NULL
Requirement	NULL
for	NULL
C5a	NULL
in	NULL
lung	NULL
vascular	NULL
injury	NULL
following	NULL
thermal	NULL
trauma	NULL
to	NULL
rat	NULL
skin	NULL
.	NULL

Shock	NULL
8	NULL
,	NULL
119-124	NULL
.	NULL

22	NULL
.	NULL

Collart	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
Baeuerle	NULL
,	NULL
P.	NULL
,	NULL
Vassalli	NULL
,	NULL
P.	NULL
(	NULL
1990	NULL
)	NULL
Regulation	NULL
of	NULL
tumor	NULL
necrosis	NULL
factor	NULL
alpha	NULL
transcription	NULL
in	NULL
macrophages	NULL
:	NULL
involvement	NULL
of	NULL
four	NULL
kappa	NULL
http	NULL
:	NULL
//www.jleukbi0.org	NULL
28	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

B-like	NULL
motifs	NULL
and	NULL
of	NULL
constitutive	NULL
and	NULL
inducible	NULL
forms	NULL
of	NULL
NF-kappa	NULL
B.	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

10	NULL
,	NULL
1498-1506	NULL
.	NULL

Collins	NULL
,	NULL
T.	NULL
,	NULL
Read	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
Neigh	NULL
,	NULL
A.	NULL
S.	NULL
,	NULL
Whitley	NULL
,	NULL
M.	NULL
Z.	NULL
,	NULL
Thanos	NULL
,	NULL
D.	NULL
,	NULL
Maniatis	NULL
,	NULL
T.	NULL
(	NULL
1995	NULL
)	NULL
Transcriptional	NULL
regulation	NULL
of	NULL
endothelial	NULL
cell	NULL
adhesion	NULL
molecules	NULL
:	NULL
NF-kappa	NULL
B	NULL
and	NULL
cytokine-inducible	NULL
enhancers	NULL
.	NULL

FASEB	NULL
J	NULL
.	NULL

9	NULL
,	NULL
899-909	NULL
.	NULL

Mulligan	NULL
,	NULL
M.	NULL
S.	NULL
,	NULL
Wilson	NULL
,	NULL
G.	NULL
P.	NULL
,	NULL
Todd	NULL
,	NULL
R.	NULL
E.	NULL
,	NULL
III	NULL
,	NULL
Smith	NULL
,	NULL
C.	NULL
W.	NULL
,	NULL
Anderson	NULL
,	NULL
D.	NULL
C.	NULL
,	NULL
Varani	NULL
,	NULL
J.	NULL
,	NULL
Issekutz	NULL
,	NULL
T.	NULL
,	NULL
Miyasaka	NULL
,	NULL
M.	NULL
,	NULL
Tamatani	NULL
,	NULL
T.	NULL
,	NULL
Rusche	NULL
,	NULL
J.	NULL
R.	NULL
,	NULL
Vaporiciyan	NULL
,	NULL
A	NULL
.	NULL

A.	NULL
,	NULL
Ward	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Role	NULL
of	NULL
31	NULL
,	NULL
3	NULL
;	NULL
integrins	NULL
and	NULL
ICAM-1	NULL
in	NULL
lung	NULL
injury	NULL
following	NULL
deposition	NULL
of	NULL
IgG	NULL
and	NULL
IgA	NULL
immune	NULL
complexes	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

150	NULL
,	NULL
2407-2417	NULL
.	NULL

Mulligan	NULL
,	NULL
M.	NULL
S.	NULL
,	NULL
Schmid	NULL
,	NULL
E.	NULL
,	NULL
Beck-Schimmer	NULL
,	NULL
B.	NULL
,	NULL
Till	NULL
,	NULL
G.	NULL
O.	NULL
,	NULL
Fried	NULL
]	NULL
,	NULL
H.	NULL
P.	NULL
,	NULL
Brauer	NULL
,	NULL
R.	NULL
B.	NULL
,	NULL
Hugli	NULL
,	NULL
T.	NULL
E.	NULL
,	NULL
Miyasaka	NULL
,	NULL
M.	NULL
,	NULL
Warner	NULL
,	NULL
R.	NULL
L.	NULL
,	NULL
Johnson	NULL
,	NULL
K.	NULL
J.	NULL
,	NULL
Ward	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
Requirement	NULL
and	NULL
role	NULL
of	NULL
C5a	NULL
in	NULL
acute	NULL
lung	NULL
inflammatory	NULL
injury	NULL
in	NULL
rats	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

98	NULL
,	NULL
508-512	NULL
.	NULL

Mulligan	NULL
,	NULL
M.	NULL
S.	NULL
,	NULL
Varani	NULL
,	NULL
J.	NULL
,	NULL
Dame	NULL
,	NULL
M.	NULL
K.	NULL
,	NULL
Lane	NULL
,	NULL
C.	NULL
L.	NULL
,	NULL
Smith	NULL
,	NULL
C.	NULL
W.	NULL
,	NULL
Anderson	NULL
,	NULL
D.	NULL
C.	NULL
,	NULL
Ward	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Role	NULL
of	NULL
endothelial-leukocyte	NULL
27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30.	NULL
adhesion	NULL
molecule	NULL
1	NULL
(	NULL
ELAM-1	NULL
)	NULL
in	NULL
neutrophil-mediated	NULL
Tung	NULL
injury	NULL
in	NULL
rats	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

88	NULL
,	NULL
1396-1406	NULL
.	NULL

Johnson	NULL
,	NULL
K.	NULL
J.	NULL
,	NULL
Ward	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

(	NULL
1974	NULL
)	NULL
Acute	NULL
immunologic	NULL
pulmonary	NULL
alveolitis	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

54	NULL
,	NULL
349-357	NULL
.	NULL

Mulligan	NULL
,	NULL
M.	NULL
S.	NULL
,	NULL
Warner	NULL
,	NULL
R.	NULL
L.	NULL
,	NULL
Foreback	NULL
,	NULL
J.	NULL
L.	NULL
,	NULL
Shanley	NULL
,	NULL
T.	NULL
P.	NULL
,	NULL
Ward	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

(	NULL
1997	NULL
)	NULL
Protective	NULL
effects	NULL
of	NULL
IL-4	NULL
,	NULL
IL-10	NULL
,	NULL
IL-12	NULL
,	NULL
and	NULL
IL-13	NULL
in	NULL
IgG	NULL
immune	NULL
complex-induced	NULL
lung	NULL
injury	NULL
:	NULL
role	NULL
of	NULL
endogenous	NULL
IL-12	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

159	NULL
,	NULL
3483-3489	NULL
.	NULL

Maier	NULL
,	NULL
R.	NULL
,	NULL
Ganu	NULL
,	NULL
V.	NULL
,	NULL
Lotz	NULL
,	NULL
M.	NULL
(	NULL
1993	NULL
)	NULL
Interleukin-11	NULL
,	NULL
an	NULL
inducible	NULL
cytokine	NULL
in	NULL
human	NULL
articular	NULL
chondrocytes	NULL
and	NULL
synoviocytes	NULL
,	NULL
stimulates	NULL
the	NULL
production	NULL
of	NULL
the	NULL
tissue	NULL
inhibitor	NULL
of	NULL
metalloproteinases	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268	NULL
,	NULL
21527-21532	NULL
.	NULL

Yin	NULL
,	NULL
T.	NULL
,	NULL
Schendel	NULL
,	NULL
P.	NULL
,	NULL
Yang	NULL
,	NULL
Y.	NULL
C.	NULL
(	NULL
1992	NULL
)	NULL
Enhancement	NULL
of	NULL
in	NULL
vitro	NULL
and	NULL
in	NULL
vivo	NULL
antigen-specific	NULL
antibody	NULL
responses	NULL
by	NULL
IL-11	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

175	NULL
,	NULL
211-216	NULL
.	NULL

Lentsch	NULL
et	NULL
al	NULL
.	NULL

-	NULL
Regulatory	NULL
effects	NULL
of	NULL
IL-11	NULL
157	NULL

